[go: up one dir, main page]

WO2019243263A1 - Composés insecticides - Google Patents

Composés insecticides Download PDF

Info

Publication number
WO2019243263A1
WO2019243263A1 PCT/EP2019/065896 EP2019065896W WO2019243263A1 WO 2019243263 A1 WO2019243263 A1 WO 2019243263A1 EP 2019065896 W EP2019065896 W EP 2019065896W WO 2019243263 A1 WO2019243263 A1 WO 2019243263A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compounds
spp
phenyl
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2019/065896
Other languages
English (en)
Inventor
Myriem El Qacemi
Jérôme Yves CASSAYRE
André Stoller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Participations AG
Original Assignee
Syngenta Participations AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations AG filed Critical Syngenta Participations AG
Publication of WO2019243263A1 publication Critical patent/WO2019243263A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/44—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom three- or four-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • the present invention relates to certain isoxazoline derivatives, to intermediates for preparing such derivatives, to insecticidal, acaricidal, nematicidal and molluscicidal compositions comprising such derivatives and to methods of using these derivatives to control insect, acarine, nematode and mollusc pests.
  • a 1 , A 2 , A 3 and A 4 are, independently of one another, C-H, C-R 5 or N;
  • R 1 is hydrogen, C-i-Csalkyl, C-i-Csalkylcarbonyl-, C3-C6cycloalkylcarbonyl, C-i-Csalkoxy, C-i-Csalkoxy- C-i-Csalkyl, C-i-Csalkoxycarbonyl, C-i-CsalkylcarbonyloxyC-i-Csalkyl, C-i-Csalkoxycarbonylsulfanyl, Ci- C8alkylaminocarbonyloxyCi-C8alkyl, C-i-CsdialkylaminocarbonyloxyC-i-Csalkyl, Ci- C8alkylaminocarbonylCi-C8alkyl, Ci-C8alkylaminocarbonylCi-C8alkyl, Ci-CsdialkylaminocarbonylCi-C8alkyl, Ci-CsdialkylaminocarbonylCi-C8
  • R 2 is Ci-C8alkyl, C-i-Cshaloalkyl, halogen, C-i-Csalkoxy, amino, C 2 -C6alkenyl, C 2 -C6alkynyl,
  • R 3 is Ci-C8haloalkyl
  • R 4 is phenyl or phenyl substituted by one to three R 6b or pyridine or pyridine substituted by one to three
  • R 5a and R 5b are, independently of each other, hydrogen, cyano, halogen, hydroxyl, C-i-Csalkyl-, C1- Csalkyl- substituted by one to five R 6a , Ci-Csalkylthio-, Ci-Cshaloalkylthio-, Ci-Csalkylsulfinyl-, C1- Cshaloalkylsulfinyl-, Ci-Csalkylsulfonyl-, Ci-Cshaloalkylsulfonyl-, arylthio- or arylthio- wherein the aryl moiety is substituted by one to five R 7 , arylsulfinyl- or arylsulfinyl- wherein the aryl moiety is substituted by one to five R 7 , arylsulfonyl- or arylsulfonyl- wherein the aryl moiety is substituted by one
  • R 6a is independently halogen, cyano, nitro, amino, hydroxy, oxo, C-i-Csalkylamino, hydroxyimino, C1- Csalkyloxyimino, di-C-i-Csalkylamino, C-i-Csalkoxy, acetyloxy, formyloxy, C-i-Cshaloalkoxy, C1- C4alkylthio or (Ci-C4alkyl)o-3silyl;
  • R 6b is independently halogen, cyano, nitro, C-i-Csalkyl, Ci-Cshaloalkyl, amino, Ci-Csalkylamino, di-Ci- Csalkylamino, hydroxyl, Ci-C 4 alkylthio,Ci-C8alkoxy or C-i-Cshaloalkoxy;
  • R 7 is independently halogen, cyano, nitro, C-i-Csalkyl, Ci-Cshaloalkyl, Ci-Csalkoxy, or C-i-Cshaloalkoxy; or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer and N-oxide thereof.
  • Compounds of formula (I) which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrous acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as Ci-C 4 alkanecarboxylic acids which are unsubstituted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with organic sulfonic acids, such as Ci-C 4 alkane- or arylsulfonic acids which are unsubstituted or substituted, for
  • Compounds of formula (I) which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine.
  • bases for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts
  • salts with ammonia or an organic amine such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, die
  • alkyl groups occurring in the definitions of the substituents can be straight-chain or branched and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, pentyl, hexyl, nonyl, decyl and their branched isomers.
  • Alkylsulfanyl, alkylsulfinyl, alkylsulfonyl, alkylcarbonyl, alkoxy, alkenyl and alkynyl radicals are derived from the alkyl radicals mentioned.
  • the alkenyl and alkynyl groups can be mono- or polyunsaturated.
  • Halogen is generally fluorine, chlorine, bromine or iodine. This also applies, correspondingly, to halogen in combination with other meanings, such as haloalkyl or halophenyl.
  • Haloalkyl groups preferably have a chain length of from 1 to 6 carbon atoms.
  • Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2- trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1 ,1-difluoro-2,2,2-trichloroethyl, 2, 2,3,3- tetrafluoroethyl and 2,2,2-trichloroethyl.
  • Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert- butoxy and also the isomeric pentyloxy and hexyloxy radicals.
  • Alkoxyalkyl groups preferably have a chain length of 1 to 6 carbon atoms.
  • Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n-propoxymethyl, n-propoxyethyl, isopropoxymethyl or isopropoxyethyl.
  • Alkoxycarbonyl is for example methoxycarbonyl (which is C-ialkoxycarbonyl), ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, tert-butoxycarbonyl, n-pentoxycarbonyl or hexyloxy carbonyl.
  • the cycloalkyl groups preferably have from 3 to 6 ring carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
  • C2-C8alkynyl refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two to eight carbon atoms, and which is attached to the rest of the molecule by a single bond.
  • C2-C8 alkynyl examples include, but are not limited to, ethynyl, prop-1-ynyl, but-1-ynyl and but-2- ynyl.
  • C2-C8alkenyl refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond, having from two to eight carbon atoms, and which is attached to the rest of the molecule by a single bond.
  • Examples of C2-Csalkenyl include, but are not limited to, prop-1-enyl, but-1-enyl and but-2-enyl.
  • alkylcarbonyloxyalkyl refers to a group -R0C(0)R, wherein each R is, independently, C1-C8 alkyl.
  • alkoxycarbonylsulfanyl refers to a group -SC(0)0R, wherein R is C-i-Cs alkyl.
  • alkylaminocarbonyloxyalkyl refers to a group -R0C(0)NHR, wherein each R is, independently, C-i-Cs alkyl.
  • dialkylaminocarbonyloxyalkyl refers to a group -R0C(0)NRR, wherein each R is, independently, C-i-Cs alkyl.
  • alkylaminocarbonylalkyl refers to a group -RC(0)NHR, wherein each R is, independently, C-i-Cs alkyl.
  • dialkylaminocarbonylalkyl refers to a group -RC(0)NRR, wherein each R is, independently, C-i-Cs alkyl.
  • alkoxycarbonylalkylaminoalkyl refers to a group -RNH(R)C(0)0R, wherein each R is, independently, C-i-Cs alkyl.
  • Heteroaryl groups preferably are the 5-6 membered heteroaryls or the 5-6 membered heteroaryls substituted by one to three R 7 where the heteroaryl groups contain 1 to 3 hetero atoms selected from the group consisting of nitrogen, oxygen and sulfur, it not being possible for each ring system to contain more than 2 oxygen atoms and more than 2 sulfur atoms.
  • monocyclic groups include pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl (e.g.
  • the compounds of formula (I) according to the invention also include hydrates which may be formed during the salt formation.
  • a 1 , A 2 , A 3 , A 4 , B 1 ⁇ B 2 ⁇ B 3 ⁇ B 4 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6a , R 6b , R 7 , R 8 , R 9 and R 10 in relation to each compound of the present invention, including the intermediate compounds, are, in any combination (including combinations of preferred values with the original values) as set out below.
  • Preferably no more than two of A 1 , A 2 , A 3 and A 4 are nitrogen.
  • a 1 is C-H or C-R 5 ; more preferably A 1 is C-R 5 .
  • a 2 is C-H or C-R 5 ; more preferably A 2 is C-H.
  • a 3 is C-H or N; more preferably A 3 is C-H.
  • a 4 is C-H or N; more preferably A 4 is C-H.
  • a 1 is C-R 5 ;
  • a 2 is C-H;
  • a 3 is C-H; and
  • a 4 is C-H.
  • each of A 2 , A 3 and A 4 are C-H and A 1 is C-R 5 .
  • B 1 ⁇ B 2 ⁇ B 3 ⁇ B 4 -CH 2 -C CH-0-.
  • B 1 ⁇ B 2 ⁇ B 3 ⁇ B 4 is -CH 2 -N-CH 2 -CH 2 -.
  • B 1 ⁇ B 2 ⁇ B 3 ⁇ B 4 is -CH(OH)-N-CH 2 -CH 2 -.
  • B 1 --B 2 --B 3 --B 4 is -C(0)-N-CH 2 -CH 2 -.
  • R 1 is hydrogen, formyl, C-i-Csalkyl, Ci- Csalkylcarbonyl- or C-i-Csalkoxycarbonyl-; more preferably hydrogen, methyl, ethyl, methylcarbonyl-, methoxymethyl, ethoxymethyl or methoxycarbonyl; most preferably hydrogen, methoxymethyl, ethoxymethyl, methyl or methoxycarbonyl; especially hydrogen or methoxymethyl; more especially hydrogen.
  • R 1 is C-i-Csalkyl, C-i-Csalkylcarbonyl-, C3-C6cycloalkylcarbonyl, Ci- Csalkoxy, C-i-Csalkoxy-C-i-Csalkyl, C-i-Csalkoxycarbonyl, C-i-CsalkylcarbonyloxyC-i-Csalkyl, C1- C8alkoxycarbonylsulfanyl, C-i-CsalkylanninocarbonyloxyC-i-Csalkyl, C-i-CsdialkylaminocarbonyloxyC-i- Csalkyl, C-i-CsalkylanninocarbonylC-i-Csalkyl, C-i-CsdialkylanninocarbonylC-i-Csalkyl, or C-i- CsalkoxycarbonylCi-Csalkylamino
  • R 2 is Ci-C 4 alkyl or Ci-C 4 haloalkyl, halogen, amino, Ci-C 4 alkoxy, C 2 -C 4 alkenyl, C 2 - C 4 alkynyl, Ci-C 4 haloalkoxy, Ci-C 4 alkylamino, Ci-C 4 alkylamino wherein the alkyl group is substituted by R 6a , Ci-C 4 alkenylamino, -NHC(0)NR a R b , Ci-C 4 dialkylamino, Ci-C 4 dialkylamino wherein one or both of the alkyl groups are independently substituted by R 6a , Ci-C 4 dialkenylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3-C6cycloalkyl, Ci-C 4 alkyl substituted by R 6a , C 2 -C 4 alkenyl substituted by R 6b , C
  • R 3 is Ci-C 4 haloalkyl; more preferably chlorodifluoromethyl or trifluoromethyl; most preferably trifluoromethyl.
  • R 4 is preferably phenyl or phenyl substituted by one to three R 6b ; more preferably R 4 is phenyl substituted by one to three substituents selected from F, Cl, Br or CF3 ; even more preferably R 4 is phenyl substituted by one to three R 6b ; most preferably R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro- 5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl,
  • R 4 is 3-chloro-5-trifluoromethyl-phenyl, 3,5-dichloro-phenyl,
  • R 5a is halogen, hydroxyl, C-i-Csalkylthio-, C-i-Cshaloalkylthio-, C1 -Ceal kylsu Ifinyl- , C1- Cshaloalkylsulfinyl-, C-i-Csalkylsulfonyl-, C-i-Cshaloalkylsulfonyl-, C-i-Csalkyl, C2-Csalkenyl, C2- Csalkynyl, C-i-Cshaloalkyl, C2-Cshaloalkenyl, most preferably halogen, C-i-Csalkylthio- or Ci-Csalkyl, even most preferably halogen.
  • R 5b is halogen or hydrogen, most preferably hydrogen.
  • R 6a independently is cyano, halogen, Ci-C 4 alkoxy, Ci-C 4 haloalkoxy or Ci-C 4 alkylthio; more preferably fluoro, cyano, methoxy, difluoromethoxy, trifluoromethoxy or methylthio.
  • R 6b independently is halogen, cyano, Ci-C 4 alkyl, Ci-C 4 haloalkyl, Ci-C 4 alkoxy, or C1- C 4 haloalkoxy; more preferably bromo, chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, methoxy, difluoromethoxy, trifluoromethoxy; more preferably bromo, chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, methoxy, or trifluoromethoxy; especially bromo, chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, methoxy, or trifluoromethoxy; more especially fluoro, chloro, bromo, cyano or trifluoromethyl.
  • R 7 are independently from each other halogen, cyano, Ci-C 4 alkyl, Ci-C 4 haloalkyl, C1- C 4 alkoxy or Ci-C 4 haloalkoxy; more preferably, methyl, fluoro, chloro, bromo, trifluoromethyl, trifluoromethoxy, cyano or methoxy.
  • a 1 is CR 5 and A 2 , A 3 and A 4 are each CH, wherein R 5 is as defined under formula (I) above.
  • R 1 is hydrogen, formyl, C1- Csalkyl, C-i-Csalkylcarbonyl-, C-i-Csalkoxyalkyl- or C-i-Csalkoxycarbonyl.
  • R 1 is C-i-Csalkyl, C1- Csalkylcarbonyl-, C3-C6cycloalkylcarbonyl, C-i-Csalkoxy, C-i-Csalkoxy-C-i-Csalkyl, C-i-Csalkoxycarbonyl, Ci-CsalkylcarbonyloxyCi-Csalkyl, C-i-Csalkoxycarbonylsulfanyl, C-i-CsalkylaminocarbonyloxyC-i-Csalkyl, Ci-C8dialkylaminocarbonyloxyCi-C8alkyl, C-i-CsalkylaminocarbonylC-i-Csalkyl, C1- C8dialkylaminocarbonylCi-Csalkyl, or C-i-CsalkoxycarbonylC-i-Csalkylannin
  • R 2 is selected from Ci- C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C 2 -C 4 alkenyl, Ci-C 4 alkylamino, Ci-C 4 dialkylamino, Ci- C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3-C6cycloalkyl, Ci-C 4 alkyl substituted by R 6a or C3- C6cycloalkyl substituted by R 6b .
  • R 3 is Ci-C 4 haloalkyl.
  • R 4 is phenyl or phenyl substituted by one to three R 6b , wherein R 6b is as defined under formula (I) above.
  • Embodiment E6 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is hydrogen, methyl, ethyl, methoxymethyl, ethoxymethyl, methylcarbonyl-, or methoxycarbonyl; R 2 is selected from Ci-C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C 2 -C 4 alkenyl, C1- C 4 alkylamino, Ci-C 4 dialkylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3-C6cycloalkyl, C1- C 4 alkyl substituted by R 6a or C3-C6cycloalkyl substituted by R 6b , R 3 is Ci-C 4 haloalkyl; R 4 is phenyl or phenyl substituted by one to three R 6b ; wherein R 5 is
  • Embodiment E7 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is hydrogen, methyl, ethyl, methoxymethyl, ethoxymethyl, methylcarbonyl-, or methoxycarbonyl; R 2 is selected from Ci-C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C 2 -C 4 alkenyl, C1- C 4 alkylamino, Ci-C 4 dialkylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3-C6cycloalkyl, C1- C 4 alkyl substituted by R 6a , or C3-C6cycloalkyl substituted by R 6b ; R 3 is Ci-C 4 haloalkyl; R 4 is phenyl or phenyl substituted by one to three R 6b ; wherein R
  • Embodiment E8 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 2 is selected from Ci-C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C2- C 4 alkenyl, Ci-C 4 alkylamino, Ci-C 4 dialkylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3- C6cycloalkyl, Ci-C 4 alkyl substituted by R 6a , or C3-C6cycloalkyl substituted by R 6b ; R 3 is
  • R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl- phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,4-dichloro- phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5-dichlorophenyl, 3,5-dichloro-4-fluoro-phenyl or 3,4,5- trichloro-phenyl; and wherein R 5 is bromo, chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, cyclopropyl, or vinyl; R 6a is independently cyano, methoxy, difluoromethoxy or trifluoromethoxy; and R 6b is independently bromo, chloro, fluoro, cyano, methyl
  • Embodiment E9 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 2 is selected from Ci-C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C2- C 4 alkenyl, Ci-C 4 alkylamino, Ci-C 4 dialkylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3- C6cycloalkyl, Ci-C 4 alkyl substituted by R 6a , or C3-C6cycloalkyl substituted by R 6b ; R 3 is
  • R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl- phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,4-dichloro- phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5-dichlorophenyl, 3,5-dichloro-4-fluoro-phenyl or 3,4,5- trichloro-phenyl; wherein R 5 is bromo, chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, cyclopropyl, or vinyl; R 6a is independently fluoro, cyano, methoxy, difluoromethoxy or trifluoromethoxy; and R 6b is independently bromo, chloro, fluoro, cyano
  • Embodiment E10 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 2 is selected from methyl, ethyl, CH2F, CH2CI, OHSBG, CHF2, fluorine, cyclopropyl, 1-cyanocyclopropyl, 1-methylcyclopropyl, cyclobutyl, dimethylamino, methylamino, ethylamine, isopropylamino, propylamino, isopropylmethylamino, cyclobutylmethylamino,
  • R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5- trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,5-dichloro-4-fluoro-phenyl, 3,4- dichloro-phenyl, 3-trifluoromethyl-phenyl, 4-bro
  • Embodiment E1 1 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro, bromo, trifluoromethyl, or methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5- trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,5-bis- (trifluoromethyl)-phenyl, 4-bromo-3,5-dichlorophenyl, 3,4,5-trichloro-phenyl, 3,5-dichloro
  • Embodiment E12 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro or methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5- bis-(trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5- dibromo-phenyl, 3,5-dichloro-phenyl, 3,4-dichloro-phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5- dichlorophenyl, 4-fluoro-3,5-dichlorophenyl or 3,4,5-trichloro-phenyl, 3,5
  • Embodiment E13 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro, bromo, trifluoromethyl, fluoro, or methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; , and R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di-substituted pyridyl where the substituents are independently selected from chloro, bromo, fluoro and trifluoromethyl.
  • Embodiment E14 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro or methyl; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5-dichloro-phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5- trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3-chloro-5-trifluoromethyl-phenyl.
  • Embodiment E15 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-bis- (trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5- dibromo-phenyl, 3,5-dichloro-phenyl, 3,4-dichloro-phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5- dichlorophenyl, 4-fluoro-3,5-dichlorophenyl or 3,4,5-trichloro-phenyl, 3,5-dich
  • Embodiment E16 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2 or fluorine, and R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di-substituted pyridyl where the substituents are independently selected from chloro, bromo, fluoro and trifluoromethyl.
  • Embodiment E17 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2 or fluorine; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5- dichloro-phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3- chloro-5-trifluoromethyl-phenyl.
  • Embodiment E18 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is bromo; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl ; and R 4 is 3,5-bis- (trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5- dibromo-phenyl, 3,5-dichloro-phenyl, 3,4-dichloro-phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5- dichlorophenyl, 4-fluoro-3,5-dichlorophenyl or 3,4,5-trichloro-phenyl, 3,5-
  • Embodiment E19 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is bromo; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl, and R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di- substituted pyridyl where the substituents are independently selected from chloro, bromo, fluoro and trifluoromethyl.
  • Embodiment E20 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is bromo; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2 or fluorine; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5- dichloro-phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3- chloro-5-trifluoromethyl-phenyl.
  • Embodiment E21 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is trifluoromethyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5- bis-(trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5- dibromo-phenyl, 3,5-dichloro-phenyl, 3,4-dichloro-phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5- dichlorophenyl, 4-fluoro-3,5-dichlorophenyl or 3,4,5-trichloro-phenyl, 3,5
  • Embodiment E22 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is trifluoromethyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1- cyanocyclopropyl, and R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di-substituted pyridyl where the substituents are independently selected from chloro, bromo, fluoro and trifluoromethyl.
  • Embodiment E23 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is trifluoromethyl; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2 or fluorine; and R 4 is 3,5-dichloro-4-fluoro- phenyl, 3,5-dichloro-phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl- phenyl or 3-chloro-5-trifluoromethyl-phenyl.
  • Embodiment E24 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-bis- (trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5- dibromo-phenyl, 3,5-dichloro-phenyl, 3,4-dichloro-phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5- dichlorophenyl, 4-fluoro-3,5-dichlorophenyl or 3,4,5-trichloro-phenyl, 3,5-dich
  • Embodiment E25 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl, and R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di- substituted pyridyl where the substituents are independently selected from chloro, bromo, fluoro and trifluoromethyl.
  • Embodiment E26 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is hydrogen; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is methyl; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2 or fluorine; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5- dichloro-phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3- chloro-5-trifluoromethyl-phenyl.
  • Embodiment E27 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl,
  • R 2 is selected Ci-C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C 2 -C 4 alkenyl, Ci-C 4 alkylamino, C1- C 4 dialkylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3-C6cycloalkyl, Ci-C 4 alkyl substituted by R 6a , or C3-C6cycloalkyl substituted by R 6b ; R 4 is phenyl or phenyl substituted by one to three R 6b ; wherein R 5 is halogen or C-i-Csalkyl, Cs-Cscycloalkyl, C-i-Cshaloalkyl, or C2-Csalkenyl; R 6a is independently halogen, cyan
  • Embodiment E28 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl,
  • R 2 is selected Ci-C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C 2 -C 4 alkenyl, Ci-C 4 alkylamino, Ci- C 4 dialkylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3-C6cycloalkyl, Ci-C 4 alkyl substituted by R 6a , or C3-C6cycloalkyl substituted by R 6b ;
  • R 3 is Ci-C 4 haloalkyl;
  • R 4 is phenyl or phenyl substituted by one to three R 6b ; wherein R 5 is halogen, cyano, Ci-C 4 alkyl, C3-C6cycloalkyl, Ci-C 4 haloalkyl, C2- C 4 alkeny
  • Embodiment E29 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl,
  • R 2 is selected from Ci-C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C 2 -C 4 alkenyl, Ci-C 4 alkylamino, C1- C 4 dialkylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3-C6cycloalkyl, Ci-C 4 alkyl substituted by R 6a , or C3-C6cycloalkyl substituted by R 6b ;
  • R 3 is chlorodifluoromethyl or trifluoromethyl;
  • R 4 is 3,5-bis- (trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5- dibromo-phenyl, 3,5-dichlor
  • Embodiment E30 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl,
  • R 2 is selected from Ci-C 4 alkyl, Ci-C 4 haloalkyl, halogen, amino, C 2 -C 4 alkenyl, Ci-C 4 alkylamino, C1- C 4 dialkylamino, Ci-C 4 haloalkylamino, Ci-C 4 dihaloalkylamino, C3-C6cycloalkyl, Ci-C 4 alkyl substituted by R 6a , or C3-C6cycloalkyl substituted by R 6b ;
  • R 3 is chlorodifluoromethyl or trifluoromethyl;
  • R 4 is 3,5-bis- (trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5- dibromo-phenyl, 3,5-dichlor
  • Embodiment E31 of formula (I) provides compounds of formula (I) wherein A 1 is CR 5 and A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl,
  • R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1- cyanocyclopropyl;
  • R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5-trifluoromethyl-phenyl, 3-bromo-5- trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,5-dichloro-4-fluoro-phenyl, 3,4- dichloro-phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5-dichlorophenyl, 4-fluoro-3,5-dichlorophenyl or
  • R 5 is bromo, chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, cyclopropyl, or vinyl;
  • Embodiment E32 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro, bromo, trifluoromethyl, or methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3- chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl, 3,5- dibromo-phenyl, 3,5-
  • Embodiment E33 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro or methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5- trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,4- dich
  • Embodiment E34 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro, bromo, trifluoromethyl, fluoro, or methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl, and R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, flu
  • Embodiment E35 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro or methyl; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5-dichloro- phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3-chloro-5- tri
  • Embodiment E36 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5- trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,4- dichloro-
  • Embodiment E37 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro; R 2 is selected from methyl, ethyl, CH2F,
  • R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di-substituted pyridyl where the substituents are independently selected from chloro, bromo, fluoro and trifluoromethyl.
  • Embodiment E38 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is chloro; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5-dichloro-phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3-chloro-5- trifluoromethyl
  • Embodiment E39 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is bromo; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5- trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,4- dichloro
  • Embodiment E40 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is bromo; R 2 is selected from methyl, ethyl, CH2F,
  • R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di-substituted pyridyl where the substituents are independently selected from chloro, bromo, fluoro and trifluoromethyl.
  • Embodiment E41 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is bromo; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5-dichloro-phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3-chloro-5- trifluoro
  • Embodiment E42 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is trifluoromethyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5- trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,4- dich
  • Embodiment E43 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is trifluoromethyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl, and R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di-
  • Embodiment E44 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is trifluoromethyl; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5-dichloro- phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3-chloro-5- tri
  • Embodiment E45 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is methyl; R 2 is selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3-chloro-5- trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,4- dichloro-
  • Embodiment E46 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is chlorodifluoromethyl or trifluoromethyl; A 1 is CR 5 , wherein R 5 is methyl; R 2 is selected from methyl, ethyl, CH2F,
  • R 4 is phenyl, pyridyl, mono-, di- or tri-substituted phenyl where the substituents are independently selected from the group consisting of chloro, bromo, fluoro and trifluoromethyl, or mono- or di-substituted pyridyl where the substituents are independently selected from chloro, bromo, fluoro and trifluoromethyl.
  • Embodiment E47 of formula (I) provides compounds of formula (I) wherein A 2 , A 3 and A 4 are each CH; R 1 is methoxymethyl, ethoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylcarbonyloxymethyl, 1- methylethylcarbonyloxymethyl or 1 , 1-dimethylethylcarbonyloxymethyl; R 3 is trifluoromethyl; A 1 is CR 5 , wherein R 5 is methyl; R 2 is independently selected from methyl, ethyl, CH2F, dimethylamino, CHF2, fluorine, cyclopropyl or 1-cyanocyclopropyl; and R 4 is 3,5-dichloro-4-fluoro-phenyl, 3,5-dichloro-phenyl, 3,4,5-trichloro-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3-trifluoromethyl-phenyl or 3-chloro-5- trifluoromethyl
  • the invention provides compounds of formula (IA)
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to 47.
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to 47.
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to E47.
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to E47.
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to E47.
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to E47.
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 , R 4 , R 5a and R 5b and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to E47.
  • R 5a is halogen, hydroxyl, C-i-Csalkylthio-, C-i-Cshaloalkylthio-, Ci- Csalkylsulfinyl-, C-i-Cshaloalkylsulfinyl-, C-i-Csalkylsulfonyl-, C-i-Cshaloalkylsulfonyl-, C-i-Csalkyl, C2- Cealkenyl, C2-C8alkynyl, C-i-Cshaloalkyl, C2-C8haloalkenyl, most preferably halogen, C-i-Csalkylthio- or Ci-Cealkyl.
  • R 5b is halogen or hydrogen.
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to E47.
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or A/-oxide thereof. Further preferred in this embodiment are the embodiments E1 to E47.
  • the present invention also provides intermediates useful for the preparation of compounds of formula (I). Certain intermediates are novel and as such form a further aspect of the invention. One group of novel intermediates are compounds of formula (lnt-1)
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 and R 2 are the same as the preferences set out for the
  • a 1 , A 2 , A 3 , A 4 , R 1 and R 2 are as defined for a compound of formula (I);
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 and R 2 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
  • R 1 and R 2 are as defined for a compound of formula (I); or a salt or A/-oxide thereof.
  • the preferences for R 1 and R 2 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
  • R , R 2 and R 3 are independently of each other optionally substituted alkyl or optionally substituted phenyl, R 4 is optionally substituted alkyl, and A 1 , A 2 , A 3 , A 4 , R 1 and R 2 are as defined for a compound of formula (I); or a salt or A/-oxide thereof.
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 and R 2 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 and R 2 may be the same as for formula (IA),
  • R 1’ , R 2 and R 3 are each independently C-i-Csalkyl or phenyl.
  • R 4 ' is C-i-Cs alkyl.
  • G 2 is O or S
  • R 1’ , R 2 and R 3 are independently of each other optionally substituted alkyl or optionally substituted phenyl
  • a 1 , A 2 , A 3 , A 4 , R 1 and R 2 are as defined for a compound of formula (I); or a salt or A/-oxide thereof.
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 and R 2 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
  • R 1 , A 2 , A 3 , A 4 , R 1 and R 2 may be the same as for formula (IA), (IB), (IC), (ID), (IE), (IF), (IG), (IH), (IJ), (IK), (IL) and (IM).
  • R 1’ , R 2 and R 3 are each independently C-i-Csalkyl or phenyl.
  • R 4’ is C-i-Cs alkyl.
  • W is hydrogen or optionally substituted aryl
  • Y is optionally substituted aryl
  • Z is optionally substituted alkyl or optionally substituted arylalkylene
  • a 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 are as defined for a compound of formula (I); or a salt or A/-oxide thereof.
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 may be the same as for formula (IA), (IB), (IC), (ID), (IE), (IF), (IG), (IH), (IJ), (IK), (IL) and (IM).
  • W is hydrogen or phenyl.
  • Y is phenyl.
  • Z is C-i-Csalkyl, or phenyl-C-i-Csalkyl.
  • Z is optionally substituted alkyl or optionally substituted arylalkylene, and A 1 , A 2 , A 3 , A 4 , R 1 ,
  • R 2 , R 3 and R 4 are as defined for a compound of formula (I); or a salt or A/-oxide thereof.
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 may be the same as for formula (IA), (IB), (IC), (ID), (IE), (IF), (IG), (IH), (IJ), (IK), (IL) and (IM).
  • Z is C-i-Csalkyl, or phenyl-C-i-Csalkyl.
  • Another group of novel intermediates are compounds of formula (Int-IX)
  • Q 3 is CH2-OR 4’ or CH2-CN
  • R , R 2 and R 3 are independently of each other optionally substituted alkyl or optionally substituted phenyl
  • R 4 is optionally substituted alkyl
  • a 1 , A 2 , A 3 , A 4 , R 1 and R 2 are as defined for a compound of formula (I); or a salt or A/-oxide thereof.
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 and R 2 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
  • R 1 , A 2 , A 3 , A 4 , R 1 and R 2 may be the same as for formula (IA), (IB), (IC), (ID), (IE), (IF), (IG), (IH), (IJ), (IK), (IL) and (IM).
  • R 1’ , R 2 and R 3 are each independently C-i-Csalkyl or phenyl.
  • R 4’ is C-i-Cs alkyl.
  • Another group of novel intermediates are compounds of formula (Int-X)
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
  • the preferences for A 1 , A 2 , A 3 , A 4 , R 1 , R 2 , R 3 and R 4 may be the same as for formula (IA), (IB), (IC), (ID), (IE), (IF), (IG), (IH), (IJ), (IK), (IL) and (IM).
  • Compounds of formula (I) include at least one chiral center and may exist as compounds of formula (I*) or compounds of formula (I**):
  • compounds of formula (I**) are more biologically active than compounds of formula (I*).
  • the invention includes mixtures of compounds (I*) and (I**) in any ratio e.g. in a molar ratio of 1 :99 to 99:1 , e.g. 10:1 to 1 :10, e.g. a substantially 50:50 molar ratio.
  • the molar proportion of compound (I**) compared to the total amount of both enantiomers (or epimers) is for example greater than 50%, e.g.
  • the molar proportion of the compound of formula (I*) compared to the total amount of both enantiomers (or epimers) is for example greater than 50%, e.g. at least 55, 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, or at least 99%.
  • Enantiomerically (or epimerically) enriched mixtures of formula (I**) are preferred.
  • the invention is further illustrated by making available the following individual compounds of formula (la) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (la) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 ; similarly, Table A-2 individualises 200 compounds of formula (la) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2; and so on for Tables A-3 to A-240.
  • Table A-1 provides 200 compounds A-1.001 to A-1.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CF, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-2 provides 200 compounds A-2.001 to A-2.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CF, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-3 provides 200 compounds A-3.001 to A-3.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CF, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-4 provides 200 compounds A-4.001 to A-4.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CF, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-5 provides 200 compounds A-5.001 to A-5.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CF, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-6 provides 200 compounds A-6.001 to A-6.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCI, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-7 provides 200 compounds A-7.001 to A-7.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCI, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-8 provides 200 compounds A-8.001 to A-8.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCI, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-9 provides 200 compounds A-9.001 to A-9.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCI, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-10 provides 200 compounds A-10.001 to A-10.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCI, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-1 1 provides 200 compounds A-1 1 .001 to A-1 1.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CBr, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-12 provides 200 compounds A-12.001 to A-12.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CBr, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-13 provides 200 compounds A-13.001 to A-13.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CBr, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-14 provides 200 compounds A-14.001 to A-14.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CBr, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-15 provides 200 compounds A-15.001 to A-15.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CBr, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-16 provides 200 compounds A-16.001 to A-16.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is N, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-17 provides 200 compounds A-17.001 to A-17.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is N, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-18 provides 200 compounds A-18.001 to A-18.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is N, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-19 provides 200 compounds A-19.001 to A-19.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is N, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-20 provides 200 compounds A-20.001 to A-20.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is N, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-21 provides 200 compounds A-21 .001 to A-21.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCF3, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-22 provides 200 compounds A-22.001 to A-22.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCF3, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-23 provides 200 compounds A-23.001 to A-23.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCF3, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-24 provides 200 compounds A-24.001 to A-24.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCF3, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-25 provides 200 compounds A-25.001 to A-25.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CCF3, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-26 provides 200 compounds A-26.001 to A-26.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CH, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-27 provides 200 compounds A-27.001 to A-27.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CH, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-28 provides 200 compounds A-28.001 to A-28.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CH, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-29 provides 200 compounds A-29.001 to A-29.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CH, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-30 provides 200 compounds A-30.001 to A-30.200 of formula (la) wherein R1 is hydrogen, R3 is CF2CI, X2 is CH, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-31 provides 200 compounds A-31 .001 to A-31.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CF, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-32 provides 200 compounds A-32.001 to A-32.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CF, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-33 provides 200 compounds A-33.001 to A-33.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CF, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-34 provides 200 compounds A-34.001 to A-34.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CF, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-35 provides 200 compounds A-35.001 to A-35.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CF, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-36 provides 200 compounds A-36.001 to A-36.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCI, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-37 provides 200 compounds A-37.001 to A-37.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCI, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-38 provides 200 compounds A-38.001 to A-38.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCI, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-39 provides 200 compounds A-39.001 to A-39.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCI, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-40 provides 200 compounds A-40.001 to A-40.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCI, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-41 provides 200 compounds A-41 .001 to A-41.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CBr, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-42 provides 200 compounds A-42.001 to A-42.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CBr, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-43 provides 200 compounds A-43.001 to A-43.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CBr, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-44 provides 200 compounds A-44.001 to A-44.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CBr, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-45 provides 200 compounds A-45.001 to A-45.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CBr, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-46 provides 200 compounds A-46.001 to A-46.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is N, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-47 provides 200 compounds A-47.001 to A-47.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is N, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-48 provides 200 compounds A-48.001 to A-48.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is N, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-49 provides 200 compounds A-49.001 to A-49.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is N, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-50 provides 200 compounds A-50.001 to A-50.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is N, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-51 provides 200 compounds A-51 .001 to A-51.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCF3, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-52 provides 200 compounds A-52.001 to A-52.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCF3, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-53 provides 200 compounds A-53.001 to A-53.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCF3, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-54 provides 200 compounds A-54.001 to A-54.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCF3, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-55 provides 200 compounds A-55.001 to A-55.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CCF3, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-56 provides 200 compounds A-56.001 to A-56.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CH, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-57 provides 200 compounds A-57.001 to A-57.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CH, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-58 provides 200 compounds A-58.001 to A-58.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CH, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-59 provides 200 compounds A-59.001 to A-59.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CH, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-60 provides 200 compounds A-60.001 to A-60.200 of formula (la) wherein R1 is hydrogen, R3 is CF3, X2 is CH, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-61 provides 200 compounds A-61 .001 to A-61.200 of formula (la) wherein R1 is
  • Table A-62 provides 200 compounds A-62.001 to A-62.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CF, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-63 provides 200 compounds A-63.001 to A-63.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CF, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-64 provides 200 compounds A-64.001 to A-64.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CF, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-65 provides 200 compounds A-65.001 to A-65.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CF, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-66 provides 200 compounds A-66.001 to A-66.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCI, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-67 provides 200 compounds A-67.001 to A-67.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCI, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-68 provides 200 compounds A-68.001 to A-68.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCI, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-69 provides 200 compounds A-69.001 to A-69.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCI, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-70 provides 200 compounds A-70.001 to A-70.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCI, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-71 provides 200 compounds A-71 .001 to A-71.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CBr, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-72 provides 200 compounds A-72.001 to A-72.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CBr, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-73 provides 200 compounds A-73.001 to A-73.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CBr, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-74 provides 200 compounds A-74.001 to A-74.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CBr, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-75 provides 200 compounds A-75.001 to A-75.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CBr, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-76 provides 200 compounds A-76.001 to A-76.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is N, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-77 provides 200 compounds A-77.001 to A-77.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is N, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-78 provides 200 compounds A-78.001 to A-78.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is N, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-79 provides 200 compounds A-79.001 to A-79.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is N, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-80 provides 200 compounds A-80.001 to A-80.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is N, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-81 provides 200 compounds A-81 .001 to A-81.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-82 provides 200 compounds A-82.001 to A-82.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-83 provides 200 compounds A-83.001 to A-83.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-84 provides 200 compounds A-84.001 to A-84.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-85 provides 200 compounds A-85.001 to A-85.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-86 provides 200 compounds A-86.001 to A-86.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CH, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-87 provides 200 compounds A-87.001 to A-87.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CH, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-88 provides 200 compounds A-88.001 to A-88.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CH, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-89 provides 200 compounds A-89.001 to A-89.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CH, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-90 provides 200 compounds A-90.001 to A-90.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF2CI, X2 is CH, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-91 provides 200 compounds A-91 .001 to A-91.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CF, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-92 provides 200 compounds A-92.001 to A-92.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CF, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-93 provides 200 compounds A-93.001 to A-93.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CF, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-94 provides 200 compounds A-94.001 to A-94.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CF, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-95 provides 200 compounds A-95.001 to A-95.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CF, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-96 provides 200 compounds A-96.001 to A-96.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCI, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-97 provides 200 compounds A-97.001 to A-97.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCI, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-98 provides 200 compounds A-98.001 to A-98.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCI, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-99 provides 200 compounds A-99.001 to A-99.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCI, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-100 provides 200 compounds A-100.001 to A-100.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCI, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-101 provides 200 compounds A-101.001 to A-101 .200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CBr, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-102 provides 200 compounds A-102.001 to A-102.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CBr, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-103 provides 200 compounds A-103.001 to A-103.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CBr, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-104 provides 200 compounds A-104.001 to A-104.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CBr, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-105 provides 200 compounds A-105.001 to A-105.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CBr, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-106 provides 200 compounds A-106.001 to A-106.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is N, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-107 provides 200 compounds A-107.001 to A-107.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is N, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-108 provides 200 compounds A-108.001 to A-108.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is N, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-109 provides 200 compounds A-109.001 to A-109.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is N, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-1 10 provides 200 compounds A-1 10.001 to A-1 10.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is N, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-1 1 1 provides 200 compounds A-1 1 1.001 to A-1 1 1 .200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCF3, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-1 12 provides 200 compounds A-1 12.001 to A-1 12.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCF3, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-1 13 provides 200 compounds A-1 13.001 to A-1 13.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCF3, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-1 14 provides 200 compounds A-1 14.001 to A-1 14.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCF3, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-1 15 provides 200 compounds A-1 15.001 to A-1 15.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CCF3, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-1 16 provides 200 compounds A-1 16.001 to A-1 16.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CH, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-1 17 provides 200 compounds A-1 17.001 to A-1 17.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CH, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-1 18 provides 200 compounds A-1 18.001 to A-1 18.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CH, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-1 19 provides 200 compounds A-1 19.001 to A-1 19.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CH, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-120 provides 200 compounds A-120.001 to A-120.200 of formula (la) wherein R1 is methoxymethyl, R3 is CF3, X2 is CH, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-121 provides 200 compounds A-121.001 to A-121 .200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CF, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-122 provides 200 compounds A-122.001 to A-122.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CF, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-123 provides 200 compounds A-123.001 to A-123.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CF, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-124 provides 200 compounds A-124.001 to A-124.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CF, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-125 provides 200 compounds A-125.001 to A-125.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CF, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-126 provides 200 compounds A-126.001 to A-126.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCI, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-127 provides 200 compounds A-127.001 to A-127.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCI, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-128 provides 200 compounds A-128.001 to A-128.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCI, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-129 provides 200 compounds A-129.001 to A-129.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCI, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-130 provides 200 compounds A-130.001 to A-130.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCI, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-131 provides 200 compounds A-131.001 to A-131 .200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CBr, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-132 provides 200 compounds A-132.001 to A-132.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CBr, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-133 provides 200 compounds A-133.001 to A-133.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CBr, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-134 provides 200 compounds A-134.001 to A-134.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CBr, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-135 provides 200 compounds A-135.001 to A-135.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CBr, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-136 provides 200 compounds A-136.001 to A-136.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is N, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-137 provides 200 compounds A-137.001 to A-137.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is N, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-138 provides 200 compounds A-138.001 to A-138.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is N, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-139 provides 200 compounds A-139.001 to A-139.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is N, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-140 provides 200 compounds A-140.001 to A-140.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is N, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-141 provides 200 compounds A-141.001 to A-141 .200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-142 provides 200 compounds A-142.001 to A-142.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-143 provides 200 compounds A-143.001 to A-143.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-144 provides 200 compounds A-144.001 to A-144.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-145 provides 200 compounds A-145.001 to A-145.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CCF3, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-146 provides 200 compounds A-146.001 to A-146.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CH, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-147 provides 200 compounds A-147.001 to A-147.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CH, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-148 provides 200 compounds A-148.001 to A-148.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CH, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-149 provides 200 compounds A-149.001 to A-149.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CH, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-150 provides 200 compounds A-150.001 to A-150.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF2CI, X2 is CH, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-151 provides 200 compounds A-151.001 to A-151 .200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CF, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-152 provides 200 compounds A-152.001 to A-152.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CF, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-153 provides 200 compounds A-153.001 to A-153.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CF, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-154 provides 200 compounds A-154.001 to A-154.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CF, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-155 provides 200 compounds A-155.001 to A-155.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CF, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-156 provides 200 compounds A-156.001 to A-156.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCI, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-157 provides 200 compounds A-157.001 to A-157.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCI, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-158 provides 200 compounds A-158.001 to A-158.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCI, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-159 provides 200 compounds A-159.001 to A-159.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCI, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-160 provides 200 compounds A-160.001 to A-160.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCI, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-161 provides 200 compounds A-161.001 to A-161 .200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CBr, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-162 provides 200 compounds A-162.001 to A-162.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CBr, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-163 provides 200 compounds A-163.001 to A-163.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CBr, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-164 provides 200 compounds A-164.001 to A-164.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CBr, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-165 provides 200 compounds A-165.001 to A-165.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CBr, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-166 provides 200 compounds A-166.001 to A-166.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is N, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-167 provides 200 compounds A-167.001 to A-167.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is N, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-168 provides 200 compounds A-168.001 to A-168.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is N, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-169 provides 200 compounds A-169.001 to A-169.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is N, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-170 provides 200 compounds A-170.001 to A-170.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is N, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-171 provides 200 compounds A-171.001 to A-171 .200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCF3, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-172 provides 200 compounds A-172.001 to A-172.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCF3, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-173 provides 200 compounds A-173.001 to A-173.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCF3, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-174 provides 200 compounds A-174.001 to A-174.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCF3, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-175 provides 200 compounds A-175.001 to A-175.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CCF3, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-176 provides 200 compounds A-176.001 to A-176.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CH, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-177 provides 200 compounds A-177.001 to A-177.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CH, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-178 provides 200 compounds A-178.001 to A-178.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CH, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-179 provides 200 compounds A-179.001 to A-179.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CH, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-180 provides 200 compounds A-180.001 to A-180.200 of formula (la) wherein R1 is ethoxymethyl, R3 is CF3, X2 is CH, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-181 provides 200 compounds A-181.001 to A-181 .200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CF, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-182 provides 200 compounds A-182.001 to A-182.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CF, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-183 provides 200 compounds A-183.001 to A-183.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CF, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-184 provides 200 compounds A-184.001 to A-184.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CF, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-185 provides 200 compounds A-185.001 to A-185.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CF, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-186 provides 200 compounds A-186.001 to A-186.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCI, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-187 provides 200 compounds A-187.001 to A-187.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCI, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-188 provides 200 compounds A-188.001 to A-188.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCI, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-189 provides 200 compounds A-189.001 to A-189.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCI, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-190 provides 200 compounds A-190.001 to A-190.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCI, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-191 provides 200 compounds A-191.001 to A-191 .200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CBr, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-192 provides 200 compounds A-192.001 to A-192.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CBr, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-193 provides 200 compounds A-193.001 to A-193.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CBr, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-194 provides 200 compounds A-194.001 to A-194.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CBr, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-195 provides 200 compounds A-195.001 to A-195.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CBr, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-196 provides 200 compounds A-196.001 to A-196.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is N, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-197 provides 200 compounds A-197.001 to A-197.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is N, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-198 provides 200 compounds A-198.001 to A-198.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is N, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-199 provides 200 compounds A-199.001 to A-199.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is N, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-200 provides 200 compounds A-200.001 to A-200.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is N, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-201 provides 200 compounds A-201.001 to A-201 .200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCF3, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-202 provides 200 compounds A-202.001 to A-202.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCF3, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-203 provides 200 compounds A-203.001 to A-203.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCF3, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-204 provides 200 compounds A-204.001 to A-204.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCF3, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-205 provides 200 compounds A-205.001 to A-205.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CCF3, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-206 provides 200 compounds A-206.001 to A-206.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CH, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-207 provides 200 compounds A-207.001 to A-207.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CH, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-208 provides 200 compounds A-208.001 to A-208.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CH, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-209 provides 200 compounds A-209.001 to A-209.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CH, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-210 provides 200 compounds A-210.001 to A-210.200 of formula (la) wherein R1 is methyl, R3 is CF2CI, X2 is CH, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-21 1 provides 200 compounds A-21 1.001 to A-21 1 .200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CF, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-212 provides 200 compounds A-212.001 to A-212.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CF, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-213 provides 200 compounds A-213.001 to A-213.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CF, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-214 provides 200 compounds A-214.001 to A-214.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CF, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-215 provides 200 compounds A-215.001 to A-215.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CF, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-216 provides 200 compounds A-216.001 to A-216.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCI, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-217 provides 200 compounds A-217.001 to A-217.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCI, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-218 provides 200 compounds A-218.001 to A-218.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCI, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-219 provides 200 compounds A-219.001 to A-219.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCI, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-220 provides 200 compounds A-220.001 to A-220.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCI, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-221 provides 200 compounds A-221.001 to A-221 .200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CBr, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-222 provides 200 compounds A-222.001 to A-222.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CBr, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-223 provides 200 compounds A-223.001 to A-223.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CBr, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-224 provides 200 compounds A-224.001 to A-224.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CBr, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-225 provides 200 compounds A-225.001 to A-225.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CBr, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-226 provides 200 compounds A-226.001 to A-226.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is N, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-227 provides 200 compounds A-227.001 to A-227.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is N, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-228 provides 200 compounds A-228.001 to A-228.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is N, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-229 provides 200 compounds A-229.001 to A-229.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is N, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-230 provides 200 compounds A-230.001 to A-230.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is N, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-231 provides 200 compounds A-231.001 to A-231 .200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCF3, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-232 provides 200 compounds A-232.001 to A-232.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCF3, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-233 provides 200 compounds A-233.001 to A-233.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCF3, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-234 provides 200 compounds A-234.001 to A-234.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCF3, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-235 provides 200 compounds A-235.001 to A-235.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CCF3, X3 is H and R2, R5, X1 are as defined in table P.
  • Table A-236 provides 200 compounds A-236.001 to A-236.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CH, X3 is Cl and R2, R5, X1 are as defined in table P.
  • Table A-237 provides 200 compounds A-237.001 to A-237.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CH, X3 is Br and R2, R5, X1 are as defined in table P.
  • Table A-238 provides 200 compounds A-238.001 to A-238.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CH, X3 is F and R2, R5, X1 are as defined in table P.
  • Table A-239 provides 200 compounds A-239.001 to A-239.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CH, X3 is CF3 and R2, R5, X1 are as defined in table P.
  • Table A-240 provides 200 compounds A-240.001 to A-240.200 of formula (la) wherein R1 is methyl, R3 is CF3, X2 is CH, X3 is H and R2, R5, X1 are as defined in table P.
  • the invention is further illustrated by making available the following individual compounds of formula (lb) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (lb) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 ; similarly, Table A-2 individualises 200 compounds of formula (lb) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2; and so on for Tables A-3 to A-240.
  • Tables A-1 to A-240 Compounds of formula (lc) The invention is further illustrated by making available the following individual compounds of formula (lc) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (lc) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 ; similarly, Table A-2 individualises 200 compounds of formula (lc) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2; and so on for Tables A-3 to A-240.
  • Each compound disclosed in Tables A-1 to A-240 represents a disclosure of a compound according to the compound of formula (I*) in which B 1 --B 2 --B 3 ⁇ B 4 is -CH2-N-CH2-CH2-, and a disclosure according to the compound of formula (I**) in which B 1 --B 2 --B 3 --B 4 is -CH2-N-CH2-CH2- as well as mixtures thereof.
  • the invention is further illustrated by making available the following individual compounds of formula (Id) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (Id) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 ; similarly, Table A-2 individualises 200 compounds of formula (Id) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2; and so on for Tables A-3 to A-240.
  • the invention is further illustrated by making available the following individual compounds of formula (le) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (le) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 ; similarly, Table A-2 individualises 200 compounds of formula (le) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2; and so on for Tables A-3 to A-240.
  • the invention is further illustrated by making available the following individual compounds of formula (If) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (If) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 ; similarly, Table A-2 individualises 200 compounds of formula (If) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2; and so on for Tables A-3 to A-240.
  • the invention is further illustrated by making available the following individual compounds of formula (Ig) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (Ig) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 and R 5a is Cl and R 5b is H; similarly, Table A-2 individualises 200 compounds of formula (Ig) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2 and R 5a is Cl and R 5b is H; and so on for Tables A-3 to A-240.
  • the invention is further illustrated by making available the following individual compounds of formula (Ig) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (Ig) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 and R 5a is Br and R 5b is H; similarly, Table A-2 individualises 200 compounds of formula (Ig) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2 and R 5a is Br and R 5b is H; and so on for Tables A-3 to A-240.
  • the invention is further illustrated by making available the following individual compounds of formula (Ih) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (Ih) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 ; similarly, Table A-2 individualises 200 compounds of formula (Ih) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2; and so on for Tables A-3 to A-240.
  • Each compound disclosed in Tables A-1 to A-240 represents a disclosure of a compound according to the compound of formula (I*) in which B 1 --B 2 --B 3 ⁇ B 4 is -CH(OH)-N-CH2-CH2-, and a disclosure according to the compound of formula (I**) in which B 1 --B 2 --B 3 --B 4 is -CH(OH)-N-CH2-CH2- as well as mixtures thereof.
  • the invention is further illustrated by making available the following individual compounds of formula (Ij) listed below in Tables A-1 to A-240.
  • Table A-1 individualises 200 compounds of formula (Ij) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-1 ; similarly, Table A-2 individualises 200 compounds of formula (Ij) wherein for each row of Table P, the R 1 , R 3 , X2 and X3 substituents are as defined in Table A-2; and so on for Tables A-3 to A-240.
  • Each compound disclosed in Tables A-1 to A-240 represents a disclosure of a compound according to the compound of formula (I*) in which B 1 --B 2 --B 3 ⁇ B 4 is -C(0)-N-CH 2 -CH 2 -, and a disclosure according to the compound of formula (I**) in which B 1 --B 2 --B 3 --B 4 is -C(0)-N-CH 2 -CH 2 - as well as mixtures thereof.
  • Examples of compounds of formula (Int-lll) made available are those wherein R 1 and R 2 correspond to a substituent R 1 and R 2 as defined in each of Tables A-1 to A-240 above in context of formula (Int-lll), So for example, Table A-1 individualises a compound of formula (Int-lll) wherein R 1 and R 2 are as defined in Table A-1.
  • the compounds of the invention may be made by a variety of methods as shown in Schemes 1 to 20.
  • R When R is Cl, such reactions are usually carried out in the presence of a base, and optionally in the presence of a nucleophilic catalyst. Alternatively, it is possible to conduct the reaction in a biphasic system comprising an organic solvent, preferably ethyl acetate, and an aqueous solvent, preferably a solution of sodium hydrogen carbonate.
  • a base preferably pyridine, triethylamine, 4-(dimethylamino)-pyridine (“DMAP”) or diisopropylethylamine (Hunig’s base).
  • Preferred solvents are A/,A/-dimethylacetamide, tetrahydrofuran, dioxane, 1 ,2-dimethoxyethane, ethyl acetate and toluene.
  • the reaction is carried out at a temperature of from 0°C to 100°C, preferably from 15°C to 30°C, in particular at ambient temperature.
  • Amines of formula (III) can be prepared using method 1 1 described below.
  • Acid halides of formula (II), wherein R is Cl, F or Br, may be made from carboxylic acids of formula
  • Carboxylic acids of formula (II), wherein R is OH may be formed from esters of formula (II), wherein
  • R is Ci-C6alkoxy as described for example in W009080250.
  • Compounds of formula (I) can be prepared by reacting a compound of formula (IV) wherein X B is a leaving group, for example a halogen, such as bromo, with carbon monoxide and an amine of formula
  • a catalyst such as palladium(ll) acetate or bis(triphenylphosphine)palladium(ll) dichloride
  • a ligand such as triphenylphosphine
  • a base such as sodium carbonate, pyridine, triethylamine, 4-(dimethylamino)-pyridine (“DMAP”) or diisopropyl- ethylamine (Hunig’s base)
  • a solvent such as water, A/,A/-dimethylformamide or tetrahydrofuran.
  • the reaction is carried out at a temperature of from 50°C to 200°C, preferably from 100°C to 150°C.
  • the reaction is carried out at a pressure of from 50 to 200 bar, preferably from 100 to 150 bar.
  • a 1 , A 2 , A 3 and A 4 are as described for compounds of formula (I), and P can be a leaving group, for example a halogen, such as bromo, iodo, chloro or described by one of the three groups A and B:
  • G 1 is oxygen and R is OH, Ci-Ci2alkoxy or Cl, F or Br, and R 1 and R 2 are as described for compounds of formula (I).
  • compounds of formula (VII) can be prepared by various methods from an intermediate of formula (XV) or (XVI) as shown in Scheme 4 according to similar methods to those described in W010149506.
  • the intermediates of formula (XV) can be prepared for example as described in the same reference.
  • compounds of formula (VII) can be prepared by various methods from an intermediate of formula (XVII) as shown in Scheme 5 according to similar methods to those described in W010149506.
  • the intermediates of formula (XVII) can be prepared for example as described in the same reference.
  • the reaction temperature is usually between 0 °C to 100 °C, preferably between 40 and 100 °C.
  • the reactants are usually at a dilution of e.g. between 0.1 M to 1 M.
  • the reaction time is usually between 0 and 96 hours, preferably between 0 and 12 hours.
  • Suitable bases include amines, such as triethylamine, 2,5- dimethylpiperazine, tetramethylpiperidine, 4-dimethylamino pyridine, potassium carbonate, metal alkoxides, such as sodium t-butoxide or metal fluorides, such as cesium fluoride.
  • Compounds of formula (XX) can be prepared by deprotecting and cyclizing compounds of formula (XIX). Suitable conditions for this transformation include acidic conditions, for instance the presence of strong acids such as trifluoroacetic acid, sulfonic acid or hydrochloric acid.
  • Suitable solvents can be used, for example acetone, dimethylsulfoxide, dimethylformamide, toluene, xylenes, 1 ,2- dichloroethane, dichloromethane, tetrahydrofuran, methanol ethanol, tert-butanol, water or ethyl acetate at a temperature from 0 °C to 140 °C, preferably between 0 °C and 80 °C, and at dilution of e.g. between 0.1 M to 1 M.
  • the reaction time is usually between 1 and 24 hours, preferably between 1 and 6 hours.
  • compounds of formula (VII) can be prepared by decarboxylating compounds of formula (XX). Suitable conditions for this transformation involve heating the compounds in a suitable media, which depending on the group Z may include some standard additives known by a person skilled in the art. Suitable solvents can be used, for example acetone, dimethylsulfoxide,
  • the temperature is usually between 0 °C and 200 °C, preferably between 50 and 180 °C.
  • the reactants are usually at dilution of e.g. between 0.1 M to 1 M.
  • the reaction time is usually between 0 and 96 hours, preferably between 0 and 24 hours.
  • the reaction can also be performed under microwave conditions, preferably between 40 and 180 °C, in some cases, however, it is necessary or useful to add an additive, such as a metal halide, for instance sodium chloride or potassium iodide, or a metal cyanide, such as sodium cyanide to the reaction media, or a base (e.g. when group Z is alkyl).
  • an additive such as a metal halide, for instance sodium chloride or potassium iodide, or a metal cyanide, such as sodium cyanide to the reaction media, or a base (e.g. when group Z is alkyl).
  • suitable deprotection conditions include hydrogenation conditions.
  • the most useful solvents are alcohols such as methanol or ethanol and in most cases it is advantageous to conduct the reaction at dilution between 0.1 M to 1 M, preferably 0.3 M to 0.5 M.
  • Compounds of formula (VII) can be prepared by deprotecting, decarboxylating and cyclizing compounds of formula (XIX) according to a one-pot stepwise procedure without isolating the intermediates. Suitable conditions for this transformation include acidic conditions, for instance the presence of strong acids such as trifluoroacetic acid or hydrochloric acid, or basic conditions, depending on the group Z.
  • Suitable solvents could be used, for example acetone, dimethylsulfoxide, dimethylformamide, toluene, xylenes, 1 ,2-dichloroethane, dichloromethane, tetrahydrofuran, methanol, ethanol, tert-butanol, water or ethyl acetate.
  • the temperature is usually between 0 °C and 200 °C, preferably between 50 and 180 °C. Where a solvent is used the reactants are usually at dilution of e.g. between 0.1 M to 1 M.
  • the reaction time is usually between land 96 hours, preferably between 1 and 12 hours.
  • the reaction can also be performed under microwave conditions, preferably between 40 and 180 °C. In some cases, however, it is necessary or useful to add an additive, such as a metal halide, for instance sodium chloride or potassium iodide, or a metal cyanide, such as sodium cyanide to the reaction media.
  • an additive
  • Enantiomerically enriched mixtures of compounds of formula (VII) may be prepared, for example, according to schemes 4, 5 or 6 by formation of intermediate XV, XVII or XIX via an asymmetric Michael addition, see for example J. Org. Chem. 2008, 73, 3475-3480 and references cited therein” and J. Am. Chem. Soc. 2008, 130, 6072-6073.
  • Compounds of formula (XXIII) can be prepared by reaction of compound of formula (XXI) wherein X B is a halogen, such as bromine or chlorine, with an amine compound of formula (XXII) as shown in Scheme 7 in the absence or the presence of a catalyst, such as palladium(ll) acetate or bis- (triphenylphosphine)palladium(ll) dichloride, optionally in the presence of a ligand, such as triphenylphosphine, and a base, such as sodium carbonate, pyridine, triethylamine, 4-(dimethylamino)- pyridine (“DMAP”) or diisopropylethylamine (Hunig’s base), in a solvent, such as water, N,N- dimethylformamide or tetrahydrofuran.
  • a catalyst such as palladium(ll) acetate or bis- (triphenylphosphine)palladium(ll) dichloride
  • Compounds of formula (XXIII) can be prepared by reaction of compound of formula (XXV) wherein R 4 is optionally substituted alkyl group, R 1’ , R 2 and R 3 are independently of each other optionally substituted alkyl or optionally substituted phenyl groups, with styrene of formula (XIII) according to a method developed in the literature: Tetrahedron (1996), 52, (1 ), 59-70 and Tetrahedron Letters (1993), 34, (20), 3279-82.
  • Compounds of formula (XXIX) can be prepared by reaction of compound of formula (XXVII) wherein R is OH, Ci-C6alkoxy or Cl, F or Br, with a compound of formula (XXVIII) under standard reductive amination conditions.
  • Compounds of formula (XXVII) can be prepared by many methods as described in the literature (US patent US 2005148792). 24) Compounds of formula (XXIX) can be prepared by reaction of compound of formula (XXVII) wherein R is OH, Ci-C6alkoxy or Cl, F or Br, and X is a leaving group, such as a mesylate, a tosylate or an halogen with a compound of formula (XXVIII) under standard substitution reaction conditions.
  • Compounds of formula (XXXIII) can be prepared by reaction of compound of formula (XXXV) wherein R is OH, Ci-C6alkoxy or Cl, F or Br, with a compound of formula (XXVII) under standard reductive amination conditions.
  • Compounds of formula (XXXV) can be prepared by many methods as described in the literature.
  • Compounds of formula (XXXIV) can be prepared by reaction of compound of formula (XXXII) wherein R is OH, Ci-C6alkoxy or Cl, F or Br, and X is a leaving group, such as a mesylate, a tosylate or an halogen with a compound of formula (XXVII) under standard substitution reaction conditions.
  • Compounds of formula (XLI I) can be prepared by reacting a compound of formula (XLI) with trimethylsilyldiazomethane, in the presence of an organometallic reagent, such as methyl lithium, in a suitable solvent, such as tetrahydrofuran, diethyl ether, N, N-dimethylformamide or dimethoxyethane. The reaction is carried out at a temperature of from -78°C to 100°C, preferably from -78°C to ambient temperature.
  • Compounds of formula (XLII) are either known compounds or can be prepared using methods described for example in W02007074789, preferably by reacting a compound of formula (XXXIX) with a ketone of formula (XL).
  • 2,3-dihydrofuran compounds of formula (XLII) may be prepared by isomerisation of 2,5-dihydrofuran of formula (XLVI) using a metal catalyst such as RhCI(PPfi3)3, RhH(PPh3)4,
  • a solvent such as toluene or an alcoholic solvent such as ethanol
  • the isomerisation may be performed in the presence of basic oxide metal catalysts such as MgO, CaO, SrO, or La 2 C>3 as described by K. Tanabe in Chem. Lett. 1981 , 341-342 for the isomerisation of 2,5-dihydrofuran.
  • basic oxide metal catalysts such as MgO, CaO, SrO, or La 2 C>3 as described by K. Tanabe in Chem. Lett. 1981 , 341-342 for the isomerisation of 2,5-dihydrofuran.
  • Compounds of formula (XLII) and (XLVI) can be prepared by reacting a compound of formula (XLIV) wherein X 1 is a leaving group, for example a halogen, such as iodo or bromo with a compound of formula (XLIII), in the presence of a metal, such as catalyst, such as magnesium, lithium, indium, cerium or zinc, in a suitable solvent, such as tetrahydrofuran, diethyl ether or N, N-dimethylformamide.
  • a metal such as catalyst, such as magnesium, lithium, indium, cerium or zinc
  • a suitable solvent such as tetrahydrofuran, diethyl ether or N, N-dimethylformamide.
  • Compounds of formula (XLV) can be prepared by reacting a compound of formula (XLIII) with a compound of formula (XLIV), in the presence of a metal, such as magnesium, indium, cerium, zinc, or an organolithium reagent, such as n-butyl lithium, in a suitable solvent, such as tetrahydrofuran, diethyl ether or N, N-dimethylformannide.
  • a metal such as magnesium, indium, cerium, zinc, or an organolithium reagent, such as n-butyl lithium
  • a suitable solvent such as tetrahydrofuran, diethyl ether or N, N-dimethylformannide.
  • Compounds of formula (XLII) and (XLVI) can be prepared by reacting a compound of formula (XLV) in the presence of an acid, such as p-toluenesulfonic acid or sulphuric acid, or in the presence of a dehydrating agent, such as POCI3 in a suitable solvent, such as tetrahydrofuran, diethyl ether or dichloromethane.
  • an acid such as p-toluenesulfonic acid or sulphuric acid
  • a dehydrating agent such as POCI3
  • a suitable solvent such as tetrahydrofuran, diethyl ether or dichloromethane.
  • compounds of formula (XLII) and (XLVI) can be obtained by reacting a compound of formula (XLV) in the presence of a chlorinating agent, such as thionyl chloride or oxalyl chloride, or an acetylating agent, such as acetic anhydride in the presence of a base, such as triethylamine, potassium carbonate or pyridine, in a suitable solvent, such as tetrahydrofuran, diethyl ether or dichloromethane.
  • a chlorinating agent such as thionyl chloride or oxalyl chloride
  • an acetylating agent such as acetic anhydride
  • a base such as triethylamine, potassium carbonate or pyridine
  • a suitable solvent such as tetrahydrofuran, diethyl ether or dichloromethane.
  • the reaction is usually carried out using (Triphenylphosphine)gold(l) bis(trifluoromethanesulfonyl)imidate, in the presence of a pyridine N-oxyde, such as 5-Bromo-1-oxy-nicotinic acid methyl ester and an acid, such as methanesulfonic acid, in an aprotic solvent, such as 1 ,2-dichloroethane.
  • a pyridine N-oxyde such as 5-Bromo-1-oxy-nicotinic acid methyl ester
  • an acid such as methanesulfonic acid
  • an aprotic solvent such as 1 ,2-dichloroethane.
  • the reaction is carried out at a temperature of from 0°C to 100°C, preferably from 0°C to 40°C.
  • Compounds of formula (XLVIII) can be prepared by reacting a ketone of formula (XL) with a compound of formula (XLVII), where X is a halogen. These reactions are usually carried out in the presence of a metal, such as magnesium, lithium, indium, cerium or zinc, in a suitable solvent, such as tetrahydrofuran, diethyl ether or N, N-dimethylformamide. The reaction is carried out at a temperature of from -78°C to 100°C, preferably from -78°C to ambient temperature.
  • a metal such as magnesium, lithium, indium, cerium or zinc
  • compounds of formula (XLVIII) can be prepared by reacting a compound of formula (XL) with a compound of formula (XLVII), where X is a trialkylsilyl group. These reactions are usually carried out in the presence of strong base, such as lithium diisopropylamide, in a suitable solvent, such as tetrahydrofuran, diethyl ether or N, N-dimethylformamide. The reaction is carried out at a temperature of from -78°C to 100°C, preferably from -78°C to ambient temperature.
  • Compounds of formula (XLVI) (and compounds of formula (XLII)) can be prepared by reacting a compound of formula (L) (and respectively compounds of formula (XLIX)) wherein X is a leaving group, for example a halogen, such as bromo, or a triflate, with a compound of formula (XLIV) wherein X 1 is a boron derivative, such as a boronic acid, a pinacolboronate, or a trifluoroborate salt, in a Suzuki coupling reaction, in the presence of a palladium catalyst, such as palladium acetate or
  • tetrakis(triphenylphosphine) palladium in a suitable solvent, such as 1 ,4-dioxane, toluene, acetonitrile or N, N-dimethylformamide.
  • a suitable solvent such as 1 ,4-dioxane, toluene, acetonitrile or N, N-dimethylformamide.
  • the reaction is carried out at a temperature of from -20°C to 150°C, preferably from ambient temperature to 100°C.
  • compounds of formula (XLVI) can be prepared by reacting a compound of formula (L) (and respectively compounds of formula (XLIX)) wherein X is a leaving group, for example a halogen, such as bromo, or a triflate with a compound of formula (XLIV) wherein X 1 is a trialkylstannane derivative, such as tributyltin, or respectively an organozinc derivative in a Stille or Negishi coupling reaction, in the presence of a palladium catalyst, such as palladium acetate or tetrakis(triphenylphosphine) palladium, in a suitable solvent, such as 1 ,4-dioxane, toluene, acetonitrile or N, N-dimethylformamide.
  • a palladium catalyst such as palladium acetate or tetrakis(triphenylphosphine) palladium
  • suitable solvent such as 1 ,4-d
  • Compounds of formula (XLIX) (and compounds of formula (L)) wherein X is a halogen, such as bromo, can be prepared by reacting a compound of formula (XLIII) with a brominating agent, such as phosphoric tribromide, in a suitable solvent, such as tetrahydrofuran, or chloroform, dichloromethane. The reaction is carried out at a temperature of from -40°C to 100°C, preferably from -40°C to ambient temperature.
  • a brominating agent such as phosphoric tribromide
  • compounds of formula (XLIX) (and compounds of formula (L)) wherein X is a triflate
  • a triflating agent such as triflic anhydride or N,N-bis(trifluoromethanesulfonyl)aniline
  • a base such as 4- picoline, sodium or potassium hexamethyldisilylamide, lithium diisopropylamide, triethylamine or 2,6- lutidine in a suitable solvent, such as tetrahydrofuran, chloroform or dichloromethane.
  • the reaction is carried out at a temperature of from -100°C to 150°C, preferably from -40°C to 100°C.
  • Compounds of formula (LII) can be prepared by reacting a compound of formula (LI) with the vinyl compound of formula (XIII) optionally in the presence of a suitable solvent, for example N, N- dimethylformamide, xylene, toluene, chlorobenzene or dichlorobenzene.
  • a suitable solvent for example N, N- dimethylformamide, xylene, toluene, chlorobenzene or dichlorobenzene.
  • the reaction can be performed under microwave heating preferably at temperatures up to 200°C and preferably under neat conditions using a large excess of the compound of formula (XIII) (e.g. 40 equivalents).
  • Vinyl compounds of formula (XIII) are commercially available or can be made by methods known to a person skilled in the art.
  • Compounds of formula (LI) can be made by methods known to a person skilled in the art, as described in journal of Organic Chemistry (1981 ), 46(4), 771.
  • C 4 alkylene-or C-i-Csalkylcarbonyl- or arylsulfonyl- or arylthio- can be obtained by reacting an unsaturated ketone of formula (XIV), with a sulfur nucleophile, such as thioacetic acid, hydrogen sulfide, sodium sulfide, ammonium sulfide, thiourea, benzylmercaptan, Sodium benzenethiosulfonate, potassium thiocyanate, sodium thiocyanate, sodium thiomethoxide or tert-butyl mercaptan as shown on Scheme 17.
  • Such reactions can be performed optionally in the presence of a base, such as sodium hydroxide, sodium ethoxide, sodium methoxide, sodium tert-butoxide or potassium hydroxide.
  • Such reactions can also be performed in the presence of an acid, for example p- toluenesulfonic acid, hydrochloric acid, acetic acid, in a solvent, such as methanol, ethanol, N,N- dimethylformamide, toluene, dichloromethane, ethyl acetate, acetonitrile or chlorobenzene or water, or mixtures thereof, at a temperature of from 0°C to 100°C, preferably from ambient temperature to 80°C.
  • a solvent such as methanol, ethanol, N,N- dimethylformamide, toluene, dichloromethane, ethyl acetate, acetonitrile or chlorobenzene or water, or mixtures thereof.
  • the reaction can be carried out in the presence or the absence of a dehydrating agent, such as anhydrous magnesium sulfate or molecular sieves. It can also be performed using a Dean Stark or Soxhlet apparatus that enables a constant removal of the water formed during the reaction.
  • a dehydrating agent such as anhydrous magnesium sulfate or molecular sieves. It can also be performed using a Dean Stark or Soxhlet apparatus that enables a constant removal of the water formed during the reaction.
  • the reaction is carried out at a temperature of from 0°C to 100°C, preferably from 15°C to 30°C, in particular at ambient temperature.
  • Such reactions are carried out in the presence of a base, for example an organic base, such as triethylamine or sodium acetate, or an inorganic base, such as sodium hydrogen carbonate, optionally in the presence of a solvent, for example an alcohol, such as methanol or ethanol, or water, or mixtures thereof.
  • a base for example an organic base, such as triethylamine or sodium acetate, or an inorganic base, such as sodium hydrogen carbonate
  • a solvent for example an alcohol, such as methanol or ethanol, or water, or mixtures thereof.
  • Such reactions can also be carried out in the presence of an acid or not, for example p-toluenesulfonic acid, hydrochloric acid, acetic acid, optionally in the presence of a solvent, for example an alcohol, such as methanol or ethanol, or toluene, dichloromethane, water, or mixtures thereof.
  • the reaction can be carried out in the presence or the absence of a dehydrating agent, such as anhydrous magnesium sulfate or molecular sieves. It can also be perfomed using a Dean Stark or Soxhlet apparatus that enables a constant removal of the water formed during the reaction.
  • a dehydrating agent such as anhydrous magnesium sulfate or molecular sieves. It can also be perfomed using a Dean Stark or Soxhlet apparatus that enables a constant removal of the water formed during the reaction.
  • the reaction is carried out at a temperature of from 0°C to 100°C, preferably from 15°C to 30°C, in particular at ambient temperature.
  • Compounds of formula (LI I) can be obtained by cyclizing a compound of formula (LI II) wherein Z 3 is thiol. Such reactions are usually carried out in the presence of an acid or not, for example p- toluenesulfonic acid, optionally in the presence of a solvent, for example dichloroethane, methanol, ethanol, toluene, dichloromethane or chlorobenzene. The reaction is carried out at a temperature of from 0°C to 200°C, preferably from 25°C to 100°C.
  • compounds of formula (LI I) can be obtained by cyclizing a compound of formula (LIN) wherein Z 3 is aryl substituted C-i-Csalkylsulfinyl-.
  • Such reactions are usually carried out in the presence of an acid or not, for example p-toluenesulfonic acid, trifluoroacetic acid or hydrochloric acid, optionally in the presence of a solvent, for example dichloroethane, methanol, ethanol, toluene, dichloromethane or chlorobenzene.
  • the reaction is carried out at a temperature of from 0°C to 200°C, preferably from 25°C to 100°C.
  • Such reactions usually involve first the deprotection of the thiol to give a compound of formula (X) wherein Z 3 is thiol, followed by the cyclization.
  • the deprotection conditions are different and can be made by methods known to a person skilled in the art or as described in T. W. Green, P. G. M. Wuts, Protective Groups in Organic Synthesis, Wiley-lnterscience, New York, 1999, 564-566, 740-743.
  • compounds of formula (Lll) can be obtained directly from a compound of formula (LVII) wherein Z 1 is hydrogen.
  • Such reactions are usually carried out in the presence chloramines, formed in situ from ammonia and chlorine or sodium hypochlorite or hypochlorous acid, optionally in the presence of a solvent, for example dichloroethane, methanol, ethanol, toluene, dichloromethane or chlorobenzene.
  • the reaction is carried out at a temperature of from -80°C to 40°C, preferably below - 40°C.
  • compounds of formula (Lll) can be obtained directly from a compound of formula (LIV) wherein Z 1 is cyano or halogen or arylsulfonyl- or arylthio-.
  • Such reactions are usually carried out in the presence ammonia, optionally in the presence of a solvent, for example dichloroethane, tetrahydrofuran, methanol, ethanol, toluene, dichloromethane or chlorobenzene.
  • the reaction is carried out at a temperature of from -80°C to 80°C.
  • compounds of formula (Lll) can be obtained directly from a compound of formula (LIV) wherein Z 1 is aryl-Ci-C 4 alkylene.
  • Such reactions are usually carried out in two steps- The first one involves the treatment of a compound of formula (LIV) wherein Z 1 is aryl-Ci-C 4 alkylene by a suitable oxidant, such as sulfuryl chloride or chlorine, in the presence of a solvent, for example dichloroethane, methanol, ethanol, toluene, dichloromethane or chlorobenzene, to provide a compound of formula (LIV) wherein Z 1 is chlorine.
  • the second step then involves the treatment a compound of formula (LIV) wherein Z 1 is chlorine by an ammonia source, such as ammonia or ammonium bromide in the presence of a base, in the presence of a solvent, for example
  • dichloroethane methanol, ethanol, toluene, tetrahydrofuran, dichloromethane or chlorobenzene. Both steps are usually carried out at a temperature of from -80°C to 80°C.
  • compounds of formula (Lll) can be obtained directly from a compound of formula (LIV) wherein Z 1 is hydrogen.
  • Such reactions are usually carried out in the presence of a suitable nitrogen electrophile, such as Hydroxylamine-O-sulfonic acid.
  • a suitable nitrogen electrophile such as Hydroxylamine-O-sulfonic acid.
  • Such reactions are carried out in the presence of a base, for example an organic base, such as triethylamine or sodium acetate, or an inorganic base, such as sodium hydrogen carbonate, sodium hydroxide or potassium hydroxide optionally in the presence of a solvent, for example tetrahydrofuran, toluene, an alcohol, such as methanol or ethanol, or water, or mixtures thereof.
  • the reaction is carried out at a temperature of from -80°C to 80°C.
  • Compounds of formula (LXIV) can be obtained from compounds of formula (LXI), wherein R 30 is Ci-Cisalkyl, by hydrolysis using a suitable base such as MOH, M2CO3, MHCO3 wherein M is an alkali metal such as lithium, sodium, potassium, cesium, barium etc. or an alkoxide, or in the presence of acid, such as trifluoroacetic acid or hydrochloric acid, followed by decarboxylation by heating with or without a base. The reaction is carried out at a temperature of from -20°C to 200°C, in the presence or the absence of a suitable solvent.
  • a suitable base such as MOH, M2CO3, MHCO3 wherein M is an alkali metal such as lithium, sodium, potassium, cesium, barium etc. or an alkoxide
  • acid such as trifluoroacetic acid or hydrochloric acid
  • Compounds of formula (LXIV) can also be obtained from compounds of formula (LX) via a two-step sequence: first the compounds of formula (LX) can be converted to the bicyclic intermediates of formula (LXIII) using with various activating agents like protic acids HCI, H2SO4, H3PO4 etc or Lewis acid such BF3.0Et2, or using dehydrating agents, such as MsCI, Tf20, SOCI2, (COCI)2 and POCI3.
  • activating agents like protic acids HCI, H2SO4, H3PO4 etc or Lewis acid such BF3.0Et2
  • dehydrating agents such as MsCI, Tf20, SOCI2, (COCI)2 and POCI3.
  • the compounds of formula (LXIII) can be transformed into the compounds of formula (LXIV) by heating to a temperature of from 30°C to 150°C, in the presence or the absence of a suitable solvent.
  • Compounds of formula (LX) can be obtained from compounds of formula (XIV) and compounds of formula (LIX) in presence or absence of bases such as MOH, M2CO3, MHCO3 wherein M is an alkali metal such as lithium, sodium, potassium, cesium, barium etc. or an alkoxide, at a temperature of from -20°C to 200°C.
  • bases such as MOH, M2CO3, MHCO3 wherein M is an alkali metal such as lithium, sodium, potassium, cesium, barium etc. or an alkoxide, at a temperature of from -20°C to 200°C.
  • a compound of formula (I) can be converted in a manner known per se into another compound of formula (I) by replacing one or more substituents of the starting compound of formula (I) in the customary manner by (an)other substituent(s) according to the invention.
  • Salts of compounds of formula (I) can be prepared in a manner known per se.
  • acid addition salts of compounds of formula (I) are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.
  • Salts of compounds of formula (I) can be converted in the customary manner into the free compounds I, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent.
  • Salts of compounds of formula (I) can be converted in a manner known per se into other salts of compounds of formula (I), acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.
  • a salt of inorganic acid such as hydrochloride
  • a suitable metal salt such as a sodium, barium or silver salt
  • the compounds of formula (I), which have saltforming properties can be obtained in free form or in the form of salts.
  • the compounds of formula (I) and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case.
  • Diastereomer mixtures or racemate mixtures of compounds of formula (I), in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.
  • Enantiomer mixtures such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid
  • N-oxides can be prepared by reacting a compound of the formula (I) with a suitable oxidizing agent, for example the hbCh/urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride.
  • a suitable oxidizing agent for example the hbCh/urea adduct
  • an acid anhydride e.g. trifluoroacetic anhydride
  • the compounds of formula (I) and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.
  • the compounds of formula (I) according to the invention are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favourable biocidal spectrum and are well tolerated by warm-blooded species, fish and plants.
  • the pests which may be combated and controlled by the use of the compounds of the invention include those pests associated with agriculture (which term includes the growing of crops for food and fiber products), horticulture and animal husbandry, companion animals, forestry and the storage of products of vegetable origin (such as fruit, grain and timber); those pests associated with the damage of manmade structures and the transmission of diseases of man and animals; and also nuisance pests (such as flies).
  • the active ingredients according to the invention act against all or individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina.
  • the insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i. e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate, a good activity corresponding to a destruction rate (mortality) of at least 50 to 60%.
  • Hyalomma spp. Ixodes spp., Olygonychus spp, Ornithodoros spp., Polyphagotarsone latus,
  • Panonychus spp. Phyllocoptruta oleivora, Phytonemus spp, Polyphagotarsonemus spp, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Steneotarsonemus spp, Tarsonemus spp. and Tetranychus spp.;
  • Haematopinus spp. Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.;
  • Agriotes spp. Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp, Astylus atromaculatus, Ataenius spp, Atomaria linearis, Chaetocnema tibialis, Cerotoma spp, Conoderus spp, Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp, Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa decemLineata, Lissorhoptrus spp., Liogenys spp, Maecolaspis spp, Maladera castanea, Megas
  • Thyanta spp Triatoma spp., Vatiga illudens;Acyrthosium pisum, Adalges spp, Agalliana ensigera, Agonoscena targionii, Aleurodicus spp, Aleurocanthus spp, Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp, Brachycaudus spp, Brevicoryne brassicae, Cacopsylla spp, Cavariella aegopodii Scop., Ceroplaster spp., Chrysomphalus aon
  • Neotoxoptera sp Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Peregrinus maidis, Perkinsiella spp, Phorodon humuli, Phylloxera spp, Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Quesada gigas, Recilia dorsalis, Rhopalosiphum spp., Saisset
  • Coptotermes spp Corniternes cumulans, Incisitermes spp, Macrotermes spp, Mastotermes spp, Microtermes spp, Reticulitermes spp.; Solenopsis geminate
  • Blatta spp. Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp. , Scapteriscus spp, and Schistocerca spp.;
  • Thysanoptera for example
  • the active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests.
  • Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum; beet, such as sugar or fodder beet; fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soya; oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts; cucurbits, such as pumpkins, cucumbers or melons; fibre plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruit or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers; Lauraceae, such as avocado, Cinnamonium or camphor; and also tobacco, nuts,
  • compositions and/or methods of the present invention may be also used on any ornamental and/or vegetable crops, including flowers, shrubs, broad-leaved trees and evergreens.
  • the invention may be used on any of the following ornamental species: Ageratum spp., Alonsoa spp., Anemone spp., Anisodontea capsenisis, Anthemis spp., Antirrhinum spp., Aster spp., Begonia spp. (e.g. B. elatior , B. semperflorens, B. tubereux ), Bougainvillea spp., Brachycome spp., Brassica spp.
  • Ageratum spp. Ageratum spp., Alonsoa spp., Anemone spp., Anisodontea capsenisis, Anthemis spp., Antirrhinum spp., Aster spp., Begonia spp. (e.g. B. elatior , B. semperflorens, B. tubereux ), Bougainvillea spp., Brachycome
  • Calceolaria spp. (ornamental), Calceolaria spp., Capsicum annuum, Catharanthus roseus, Canna spp., Centaurea spp., Chrysanthemum spp., Cineraria spp. (C. maritime), Coreopsis spp., Crassula coccinea, Cuphea ignea, Dahlia spp., Delphinium spp., Dicentra spectabilis, Dorotheantus spp., Eustoma grandiflorum, Forsythia spp., Fuchsia spp., Geranium gnaphalium, Gerbera spp.,
  • Gomphrena globosa Heliotropium spp., Helianthus spp., Hibiscus spp., Hortensia spp., Hydrangea spp., Hypoestes phyllostachya, Impatiens spp. (/. Walleriana), Iresines spp., Kalanchoe spp., Lantana camara, Lavatera trimestris, Leonotis leonurus, Lilium spp., Mesembryanthemum spp., Mimulus spp., Monarda spp., Nemesia spp., Tagetes spp., Dianthus spp.
  • Salvia spp. Scaevola aemola, Schizanthus wisetonensis, Sedum spp., Solanum spp., Surfinia spp., Tagetes spp., Nicotinia spp., Verbena spp., Zinnia spp. and other bedding plants.
  • the invention may be used on any of the following vegetable species: Allium spp. (A. sativum, A. cepa, A. oschaninii, A. Porrum, A. ascalonicum, A. fistulosum ), Anthriscus cerefolium, Apium graveoius, Asparagus officinalis, Beta vulgarus, Brassica spp. (B. Oleracea, B. Pekinensis, B. rapa), Capsicum annuum, Cicer arietinum, Cichorium endivia, Cichorum spp. (C. intybus, C. endivia), Citrillus lanatus, Cucumis spp. (C.
  • Preferred ornamental species include African violet, Begonia, Dahlia, Gerbera, Hydrangea, Verbena, Rosa, Kalanchoe, Poinsettia, Aster, Centaurea, Coreopsis, Delphinium, Monarda, Phlox, Rudbeckia, Sedum, Petunia, Viola, Impatiens, Geranium, Chrysanthemum, Ranunculus, Fuchsia, Salvia, Hortensia, rosemary, sage, St. Johnswort, mint, sweet pepper, tomato and cucumber.
  • the active ingredients according to the invention are especially suitable for controlling Aphis craccivora, Diabrotica balteata, Heliothis virescens, Myzus persicae, Plutella xylostella and
  • the active ingredients according to the invention are further especially suitable for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apples), Empoasca(preferably in vegetables, vineyards), Leptinotarsa (preferably in potatos) and Chilo supressalis (preferably in rice).
  • the active ingredients according to the invention are especially suitable for controlling Aphis craccivora, Diabrotica balteata, Heliothis virescens, Myzus persicae, Plutella xylostella and
  • the active ingredients according to the invention are further especially suitable for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apples), Empoasca(preferably in vegetables, vineyards), Leptinotarsa (preferably in potatos) and Chilo supressalis (preferably in rice).
  • the invention may also relate to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species; cyst-forming nematodes, Globodera rostochiensis and other Globodera species; Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species; Seed gall nematodes, Anguina species; Stem and foliar nematodes, Aphelenchoides species; Sting nematodes, Belonolai
  • Needle nematodes Longidorus elongatus and other Longidorus species; Pin nematodes,
  • Pratylenchus species Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans,
  • the compounds of the invention may also have activity against the molluscs.
  • examples of which include, for example, Ampullariidae; Arion (A. ater, A. circumscriptus, A. hortensis, A. rufus);
  • Bradybaenidae (Bradybaena fruticum); Cepaea (C. hortensis, C. Nemoralis); ochlodina; Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum); Discus (D. rotundatus); Euomphalia; Galba (G. trunculata); Helicelia (H. itala, H. obvia); Helicidae Helicigona arbustorum); Helicodiscus; Helix (H. aperta); Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L.
  • Crops are to be understood as also including those crops which have been rendered tolerant to herbicides like bromoxynil or classes of herbicides such as ALS-, EPSPS-, GS-, HPPD- and PPO- inhibitors.
  • herbicides like bromoxynil or classes of herbicides such as ALS-, EPSPS-, GS-, HPPD- and PPO- inhibitors.
  • An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® summer canola.
  • crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I® and LibertyLink®.
  • Crops are also to be understood as being those which naturally are or have been rendered resistant to harmful insects. This includes plants transformed by the use of recombinant DNA techniques, for example, to be capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria. Examples of toxins which can be expressed include 5- endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins of bacteria colonising nematodes, and toxins produced by scorpions, arachnids, wasps and fungi.
  • Vip vegetative insecticidal proteins
  • insecticidal proteins of bacteria colonising nematodes and toxins produced by scorpions, arachnids, wasps and fungi.
  • An example of a crop that has been modified to express the Bacillus thuringiensis toxin is the Bt maize KnockOut® (Syngenta Seeds).
  • An example of a crop comprising more than one gene that codes for insecticidal resistance and thus expresses more than one toxin is VipCot® (Syngenta Seeds).
  • Crops or seed material thereof can also be resistant to multiple types of pests (so-called stacked transgenic events when created by genetic modification).
  • a plant can have the ability to express an insecticidal protein while at the same time being herbicide tolerant, for example Herculex I® (Dow AgroSciences, Pioneer Hi-Bred International).
  • compositions according to the invention are the protection of stored goods and store rooms and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type.
  • the present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors; see also http://www.who.int/malaria/vector_control/irs/en/).
  • the method for controlling pests comprises applying the compositions of the invention to the target pests, to their locus or to a surface or substrate by brushing, rolling, spraying, spreading or dipping.
  • an IRS (indoor residual spraying) application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention.
  • the method for controlling such pests comprises applying a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate.
  • a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate.
  • Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention.
  • an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface.
  • it is contemplated to apply such compositions for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.
  • Substrates including non-woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like.
  • the polyesters are particularly suitable.
  • the methods of textile treatment are known, e.g. WO2008151984, W02003034823, US5631072, W02005064072, W02006128870, EP1724392, W020051 13886 or W02007090739.
  • compositions according to the invention are the field of tree injection/trunk treatment for all ornamental trees as well all sort of fruit and nut trees.
  • the compounds according to the present invention are especially suitable against wood-boring insects from the order Lepidoptera as mentioned above and from the order Coleoptera, especially against woodborers listed in the following tables X and Y:
  • the present invention may be also used to control any insect pests that may be present in turfgrass, including for example beetles, caterpillars, fire ants, ground pearls, millipedes, sow bugs, mites, mole crickets, scales, mealybugs ticks, spittlebugs, southern chinch bugs and white grubs.
  • the present invention may be used to control insect pests at various stages of their life cycle, including eggs, larvae, nymphs and adults.
  • the present invention may be used to control insect pests that feed on the roots of turfgrass including white grubs (such as Cyclocephala spp. (e.g. masked chafer, C. lurida),
  • white grubs such as Cyclocephala spp. (e.g. masked chafer, C. lurida)
  • Rhizotrogus spp. e.g. European chafer, R. majalis
  • Cotinus spp. e.g. Green June beetle, C. nitida
  • Popillia spp. e.g. Japanese beetle, P. japonica
  • Phyllophaga spp. e.g. May/June beetle
  • Ataenius spp. e.g. Black turfgrass ataenius, A. spretulus
  • Maladera spp. e.g. Asiatic garden beetle, M.
  • the present invention may also be used to control insect pests of turfgrass that are thatch dwelling, including armyworms (such as fall armyworm Spodoptera frugiperda, and common armyworm Pseudaletia unipuncta), cutworms, billbugs ( Sphenophorus spp. , such as S. venatus verstitus and S. parvulus), and sod webworms (such as Crambus spp. and the tropical sod webworm, Herpetogramma phaeopteralis).
  • armyworms such as fall armyworm Spodoptera frugiperda, and common armyworm Pseudaletia unipuncta
  • cutworms such as Sphenophorus spp. , such as S. venatus verstitus and S. parvulus
  • sod webworms such as Crambus spp. and the tropical sod webworm, Herpetogramma phaeopteralis.
  • the present invention may also be used to control insect pests of turfgrass that live above the ground and feed on the turfgrass leaves, including chinch bugs (such as southern chinch bugs, Blissus insularis), Bermudagrass mite ( Eriophyes cynodoniensis), rhodesgrass mealybug ( Antonina graminis), two-lined spittlebug ( Propsapia bicincta), leafhoppers, cutworms ( Noctuidae family), and greenbugs.
  • the present invention may also be used to control other pests of turfgrass such as red imported fire ants ( Solenopsis invicta) that create ant mounds in turf.
  • compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas.
  • ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas.
  • Anoplurida Haematopinus spp., Linognathus spp., Pediculus spp. and Phtirus spp., Solenopotes spp..
  • Nematocerina and Brachycerina for example Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Glossina spp., Calliphora spp., Glossina spp., Call
  • Siphonaptrida for example Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp..
  • Heteropterida for example Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp..
  • Actinedida Prostigmata
  • Acaridida Acaridida
  • Acarapis spp. Cheyletiella spp., Ornitrocheyletia spp., Myobia spp., Psorergatesspp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp.,
  • Pterolichus spp. Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp..
  • compositions according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and buildings.
  • compositions according to the invention can be used, for example, against the following pests: beetles such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium
  • rufovillosum Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthesrugicollis, Xyleborus spec., Tryptodend ran spec., Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec and Dinoderus minutus, and also hymenopterans such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus and Urocerus augur, and termites such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes,
  • Reticulitermes santonensis Reticulitermes lucifugus
  • Mastotermes darwiniensis Zootermopsis nevadensis and Coptotermes formosanus
  • bristletails such as Lepisma saccharina.
  • the compounds according to the invention can be used as pesticidal agents in unmodified form, but they are generally formulated into compositions in various ways using formulation adjuvants, such as carriers, solvents and surface-active substances.
  • formulation adjuvants such as carriers, solvents and surface-active substances.
  • the formulations can be in various physical forms, e.g.
  • Such formulations can either be used directly or diluted prior to use.
  • the dilutions can be made, for example, with water, liquid fertilisers, micronutrients, biological organisms, oil or solvents.
  • the formulations can be prepared e.g. by mixing the active ingredient with the formulation adjuvants in order to obtain compositions in the form of finely divided solids, granules, solutions, dispersions or emulsions.
  • the active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof.
  • the active ingredients can also be contained in very fine microcapsules.
  • Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release).
  • Microcapsules usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95 % by weight of the capsule weight.
  • the active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution.
  • the encapsulating membranes can comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art.
  • very fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the
  • microcapsules are not themselves encapsulated.
  • liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1 ,2-dichloropropane, diethanolamine, p- diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, A/,A/-dimethylformamide, dimethyl sulfoxide, 1 ,4- dioxane, di
  • Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances.
  • a large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use.
  • Surface- active substances may be anionic, cationic, non-ionic or polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes.
  • Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate; alcohol/alkylene oxide addition products, such as tridecylalcohol ethoxylate; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2- ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of
  • Further adjuvants that can be used in pesticidal formulations include crystallisation inhibitors, viscosity modifiers, suspending agents, dyes, anti-oxidants, foaming agents, light absorbers, mixing auxiliaries, antifoams, complexing agents, neutralising or pH-modifying substances and buffers, corrosion inhibitors, fragrances, wetting agents, take-up enhancers, micronutrients, plasticisers, glidants, lubricants, dispersants, thickeners, antifreezes, microbicides, and liquid and solid fertilisers.
  • compositions according to the invention can include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives.
  • the amount of oil additive in the composition according to the invention is generally from 0.01 to 10 %, based on the mixture to be applied.
  • the oil additive can be added to a spray tank in the desired concentration after a spray mixture has been prepared.
  • Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow.
  • Preferred oil additives comprise alkyl esters of C8-C22 fatty acids, especially the methyl derivatives of C12-C18 fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid (methyl laurate, methyl palmitate and methyl oleate, respectively).
  • Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10 th Edition, Southern Illinois University, 2010.
  • the inventive compositions generally comprise from 0.1 to 99 % by weight, especially from 0.1 to 95 % by weight, of compounds of the present invention and from 1 to 99.9 % by weight of a formulation adjuvant which preferably includes from 0 to 25 % by weight of a surface-active substance.
  • the rates of application vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pest to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop.
  • a general guideline compounds may be applied at a rate of from 1 to 2000 l/ha, especially from 10 to 1000 l/ha.
  • Preferred formulations can have the following compositions (weight %):
  • Emulsifiable concentrates active ingredient: 1 to 95 %, preferably 60 to 90 %
  • surface-active agent 1 to 30 %, preferably 5 to 20 %
  • liquid carrier 1 to 80 %, preferably 1 to 35 %
  • Dusts active ingredient: 0.1 to 10 %, preferably 0.1 to 5 %
  • solid carrier 99.9 to 90 %, preferably 99.9 to 99 %
  • Suspension concentrates active ingredient: 5 to 75 %, preferably 10 to 50 %
  • surface-active agent 1 to 40 %, preferably 2 to 30 %
  • Wettable powders active ingredient: 0.5 to 90 %, preferably 1 to 80 %
  • surface-active agent 0.5 to 20 %, preferably 1 to 15 %
  • solid carrier 5 to 95 %, preferably 15 to 90 %
  • Granules active ingredient: 0.1 to 30 %, preferably 0.1 to 15 %
  • solid carrier 99.5 to 70 %, preferably 97 to 85 %
  • solid carrier 99.5 to 70 %, preferably 97 to 85 %
  • the combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
  • the combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
  • Emulsions of any required dilution which can be used in plant protection, can be obtained from this concentrate by dilution with water.
  • Ready-for-use dusts are obtained by mixing the combination with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
  • the combination is mixed and ground with the adjuvants, and the mixture is moistened with water.
  • the mixture is extruded and then dried in a stream of air.
  • the finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • the finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • 28 parts of the combination are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8: 1 ).
  • This mixture is emulsified in a mixture of 1 .2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51 .6 parts of water until the desired particle size is achieved.
  • To this emulsion a mixture of 2.8 parts 1 ,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed.
  • the obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent.
  • the capsule suspension formulation contains 28% of the active ingredients.
  • the medium capsule diameter is 8-15 microns.
  • the resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
  • Formulation types include an emulsion concentrate (EC), a suspension concentrate (SC), a suspo- emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP), a soluble granule (SG) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.
  • EC emulsion concentrate
  • SC suspension concentrate
  • SE suspo- emulsion
  • CS capsule suspension
  • WG water dispersible granule
  • compositions according to the invention can be broadened considerably, and adapted to prevailing circumstances, by adding other insecticidally, acaricidally and/or fungicidally active ingredients.
  • mixtures of the compounds of formula (I) with other insecticidally, acaricidally and/or fungicidally active ingredients may also have further surprising advantages which can also be described, in a wider sense, as synergistic activity. For example, better tolerance by plants, reduced phytotoxicity, insects can be controlled in their different development stages or better behaviour during their production, for example during grinding or mixing, during their storage or during their use.
  • Suitable additions to active ingredients here are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridylmethyleneamino derivatives, macrolides, neonicotinoids and Bacillus thuringiensis preparations.
  • TX means“one compound selected from the group consisting of the compounds described in Tables 1 to 96 (including 1 a to 96a to 1 m to 96m) and Table A of the present invention”): an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628) + TX,
  • an acaricide selected from the group of substances consisting of 1 , 1-bis(4-chlorophenyl)-2- ethoxyethanol (IUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-A/-methyl-A/-1-naphthylacetamide (IUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (IUPAC name) (981 ) + TX, abamectin (1 ) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha- cypermethrin (202) + TX, amidithion (870) + TX, amidoflumet
  • TX amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, aramite (881 ) + TX, arsenous oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) +
  • TX TX
  • TX buprofezin (99) + TX, butocarboxim (103) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, calcium polysulfide (IUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbophenothion (947) + TX, CGA 50’439 (development code) (125) + TX, chinomethionat (126) + TX, chlorbenside (959) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorfenethol (968) + TX, chlorfenson (970) + TX, chlorfensulfide (971 ) + TX, chlorfenvinphos (131
  • TX quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, RA-17 (development code) (1383) + TX, rotenone (722) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, sophamide (1402) +
  • TX thuringiensin (alternative name) [CCN] + TX, triamiphos (1441 ) + TX, triarathene (1443) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trifenofos (1455) + TX, trinactin (alternative name) (653) + TX, vamidothion (847) + TX, vaniliprole [CCN] and YI-5302 (compound code) + TX,
  • an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (IUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347) + TX,
  • an anthelmintic selected from the group of substances consisting of abamectin (1 ) + TX, crufomate (101 1 ) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin (alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,
  • an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1 122) + TX, fenthion (346) + TX, pyridin-4-amine (IUPAC name) (23) and strychnine (745) + TX, a bactericide selected from the group of substances consisting of 1 -hydroxy-1 /-/-pyridine-2-thione (IUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (IUPAC name) (170) + TX, copper hydroxide (IUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1 105) + TX, dodicin (1 1 12) + TX,
  • TX hydrargaphen (alternative name) [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (IUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (61 1 ) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal (alternative name) [CCN] + TX,
  • a biological agent selected from the group of substances consisting of Adoxophyes orana GV
  • acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (alternative name) (575) + TX, Orius spp. (alternative name) (596) + TX, Paecilomyces fumosoroseus (alternative name) (613) + TX,
  • Phytoseiulus persimilis (alternative name) (644) + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741 ) + TX, Steinernema bibionis (alternative name) (742) + TX, Steinernema carpocapsae (alternative name) (742) + TX, Steinernema feltiae (alternative name) (742) + TX, Steinernema glaseri (alternative name) (742) + TX, Steinernema riobrave (alternative name) (742) + TX, Steinernema riobravis (alternative name) (742) + TX, Steinernema scapterisci (alternative name) (742) + TX, Steinernema spp.
  • a soil sterilant selected from the group of substances consisting of iodomethane (IUPAC name) (542) and methyl bromide (537) + TX,
  • a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron
  • an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (IUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (IUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (IUPAC name) (541 ) + TX, (E,Z)-tetradeca-4, 10-dien-1-yl acetate (IUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (IUPAC name) (285) + TX, (Z)-hexadec-l 1- enal (IUPAC name) (436) + TX, (Z)-hexadec-l 1-en-1-yl acetate (IUPAC name) (437) + TX, (Z)- hexadec-13-en-1 1
  • an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (IUPAC name) (591 ) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (IUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (IUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX,
  • an insecticide selected from the group of substances consisting of 1-dichloro-1-nitroethane
  • TX TX
  • crotamiton alternative name
  • crotoxyphos 1010) + TX
  • crufomate 101 1
  • TX cryolite
  • CS 708 development code
  • cyanofenphos 1019
  • TX cyanophos
  • cyclethrin [CCN] + TX
  • flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1 171 ) + TX, flumethrin (372) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, fonofos (1 191 ) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, fosmethilan (1 194) + TX, fospirate (1 195) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX
  • TX, nitrilacarb 1 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, nornicotine (traditional name) (1319) + TX, novaluron (585) + TX, noviflumuron (586) + TX, 0-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (IUPAC name) (1057) + TX, O,O-diethyl 0-4-methyl-2-oxo-2/-/-chromen-7-yl phosphorothioate (IUPAC name) (1074) + TX, O,O-diethyl 0-6-methyl-2-propylpyrimidin-4-yl phosphorothioate (IUPAC name) (1075) + TX, O,O,O',O'-tetrapropyl dithiopyrophosphate (IUPAC
  • development code (development code) (1382) + TX, rafoxanide (alternative name) [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (development code) (723) + TX, RU 25475 (development code) (1386) + TX, ryania (alternative name) (1387) + TX, ryanodine (traditional name) (1387) + TX, sabadilla (alternative name) (725) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, SI-0205 (compound code) + TX, SI-0404 (compound code) + TX, SI-0405 (compound code) + TX, silafluofen (728) + TX, SN 72129
  • TX spiromesifen (739) + TX, spirotetrmat (CCN) + TX, sulcofuron (746) + TX, sulcofuron-sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfuryl fluoride (756) + TX, sulprofos (1408) + TX, tar oils (alternative name) (758) + TX, tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufenozide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) + TX, tefluthrin (769) + TX, temephos (770) + TX, TE
  • TX zinc phosphide
  • TX zinc phosphide
  • zolaprofos 1469)
  • ZXI 8901 development code
  • a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (IUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (IUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + T
  • a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2-dichloropropane (IUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3-dichloropropene (IUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4-dichlorotetrahydrothiophene 1 ,1- dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4-chlorophenyl)-5-methylrhodanine (IUPAC name) (980) + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3-ylacetic acid (IUPAC name) (1286)
  • TX 6-isopentenylaminopurine (alternative name) (210) + TX, abamectin (1 ) + TX, acetoprole [CCN] + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541
  • phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachlorothiophene (IUPAC/ Chemical Abstracts name) (1422) + TX, thiafenox (alternative name) + TX, thionazin (1434) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (alternative name) (210) + TX, fluensulfone [318290-98-1] + TX,
  • a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,
  • a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720) + TX,
  • a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1 ,3-dione (IUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748) + TX, alpha- chlorohydrin [CCN] + TX, aluminium phosphide (640) + TX, antu (880) + TX, arsenous oxide (882) + TX, barium carbonate (891 ) + TX, bisthiosemi (912) + TX, brodifacoum (89) + TX,
  • bromadiolone (91 ) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) +
  • TX chlorophacinone (140) + TX, cholecalciferol (alternative name) (850) + TX, coumachlor (1004) + TX, coumafuryl (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacoum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301 ) + TX, flocoumafen (357) + TX, fluoroacetamide (379) + TX, flupropadine (1 183) + TX, flupropadine hydrochloride (1 183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (IUPAC name) (542) + TX, lindane (430) + TX, magnesium
  • a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (IUPAC name) (934) + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (IUPAC name) (903) + TX, farnesol with nerolidol (alternative name) (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX,
  • an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171 ) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4-amine (IUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX,
  • a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX,
  • a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX,
  • azaconazole 60207-31-0] + TX, bitertanol [70585-36-3] + TX, bromuconazole [1 16255-48-2] + TX, cyproconazole [94361-06-5] + TX, difenoconazole [1 19446-68-3] + TX, diniconazole [83657-24-3] + TX, epoxiconazole
  • TX TX, ancymidol [12771-68-5] + TX, fenarimol [60168-88-9] + TX, nuarimol [63284-71-9] + TX, bupirimate [41483-43-6] + TX, dimethirimol [5221-53-4] + TX, ethirimol [23947-60-6] + TX, dodemorph [1593-77-7] + TX, fenpropidine [67306-00-7] + TX, fenpropimorph [67564-91-4] + TX, spiroxamine [1 18134-30-8] + TX, tridemorph [81412-43-3] + TX, cyprodinil [121552-61-2] + TX, mepanipyrim [1 10235-47-7] + TX, pyrimethanil [531 12-28-0] + TX, fenpiclonil [74738-17-3] + TX, fludioxonil [13
  • TX methasulfocarb [66952-49-6] + TX, metrafenone [220899-03-6] + TX, pencycuron [66063- 05-6] + TX, phthalide [27355-22-2] + TX, polyoxins [1 1 1 13-80-7] + TX, probenazole [27605-76-1] + TX, propamocarb [25606-41-1] + TX, proquinazid [189278-12-4] + TX, pyroquilon [57369-32-1] + TX, quinoxyfen [124495-18-7] + TX, quintozene [82-68-8] + TX, sulfur [7704-34-9] + TX, tiadinil [223580-51-6] + TX, triazoxide [72459-58-6] + TX, tricyclazole [41814-78-2] + TX, triforine [26644- 46-2]
  • dicloromezotiaz [1263629-39-5] + TX; dipymetitrone [161 14-35-5] + TX; pyraziflumid [942515-63-1 ] + TX; and kappa-tefluthrin [391634-71-2] + TX; and
  • microbials including: Acinetobacter Iwoffii + TX, Acremonium alternatum + TX + TX, Acremonium cephalosporium + TX + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®) + TX, Agrobacterium radiobacter strain K84 (Galltrol-A®) +
  • TX Alternaria alternate + TX, Alternaria cassia + TX, Alternaria destruens (Smolder®) + TX,
  • Ampelomyces quisqualis (AQ10®) + TX, Aspergillus flavus AF36 (AF36®) + TX, Aspergillus flavus NRRL 21882 (Aflaguard®) + TX, Aspergillus spp.
  • Bacillus subtilis strain AQ178 + TX Bacillus subtilis strain QST 713 (CEASE® + TX, Serenade® + TX, Rhapsody®) + TX, Bacillus subtilis strain QST 714 (JAZZ®) + TX, Bacillus subtilis strain AQ153 + TX, Bacillus subtilis strain AQ743 + TX, Bacillus subtilis strain QST3002 + TX, Bacillus subtilis strain QST3004 + TX, Bacillus subtilis var.
  • amyloliquefaciens strain FZB24 (Taegro® + TX, Rhizopro®) + TX, Bacillus thuringiensis Cry 2Ae + TX, Bacillus thuringiensis CrylAb + TX, Bacillus thuringiensis aizawai GC 91 (Agree®) + TX, Bacillus thuringiensis israelensis (BMP123® + TX, Aquabac® + TX, VectoBac®) + TX, Bacillus thuringiensis kurstaki (Javelin® + TX, Deliver® + TX, CryMax® + TX, Bonide® + TX, Scutella WP® + TX, Turilav WP ® +
  • TX Astuto® + TX, Dipel WP® + TX, Biobit® + TX, Foray®) + TX, Bacillus thuringiensis kurstaki BMP
  • Beauveria bassiana (Beaugenic® + TX, Brocaril WP®) + TX, Beauveria bassiana GHA (Mycotrol ES® + TX, Mycotrol O® + TX, BotaniGuard®) + TX, Beauveria brongniartii (Engerlingspilz® + TX,
  • Bradyrhizobium japonicum (TerraMax®) + TX, Brevibacillus brevis + TX, Bacillus thuringiensis tenebrionis (Novodor®) + TX, BtBooster + TX, Burkholderia cepacia (Deny® + TX, Intercept® + TX, Blue Circle®) + TX, Burkholderia gladii + TX, Burkholderia gladioli + TX, Burkholderia spp.
  • TX Canadian thistle fungus (CBH Canadian Bioherbicide®) + TX, Candida butyri + TX, Candida famata + TX, Candida fructus + TX, Candida glabrata + TX, Candida guilliermondii + TX, Candida melibiosica + TX, Candida oleophila strain O + TX, Candida parapsilosis + TX, Candida pelliculosa + TX, Candida pulcherrima + TX, Candida reuêtii + TX, Candida saitoana (Bio-Coat® + TX, Biocure®) + TX, Candida sake + TX, Candida spp.
  • TX Cladosporium tenuissimum + TX, Clonostachys rosea (EndoFine®) + TX, Colletotrichum acutatum + TX, Coniothyrium minitans (Cotans WG®) + TX, Coniothyrium spp. + TX, Cryptococcus albidus (YIELDPLUS®) + TX, Cryptococcus humicola + TX, Cryptococcus infirmo-miniatus + TX,
  • Cryptococcus laurentii + TX TX
  • Cupriavidus campinensis + TX Cydia pomonella granulovirus (CYD-X®) + TX
  • Drechslera hawaiinensis + TX Enterobacter cloacae + TX
  • Enterobacteriaceae + TX Entomophtora virulenta (Vektor®) + TX
  • Epicoccum nigrum + TX Epicoccum purpurascens + TX, Epicoccum
  • TX Filobasidium floriforme + TX, Fusarium acuminatum + TX, Fusarium chlamydosporum + TX, Fusarium oxysporum (Fusaclean® / Biofox C®) + TX, Fusarium proliferatum + TX, Fusarium spp. + TX, Galactomyces geotrichum + TX, Gliocladium catenulatum (Primastop® + TX, Prestop®) + TX, Gliocladium roseum + TX, Gliocladium spp. (SoilGard®) + TX, Gliocladium virens (Soilgard®) + TX, Granulovirus
  • TX Halomonas spp. + TX, Halomonas subglaciescola + TX, Halovibrio variabilis + TX, Hanseniaspora uvarum + TX, Helicoverpa armigera nucleopolyhedrovirus (Helicovex®) + TX, Helicoverpa zea nuclear polyhedrosis virus (Gemstar®) + TX, Isoflavone - formononetin (Myconate®) + TX, Kloeckera apiculata + TX, Kloeckera spp.
  • Helicovex® Helicoverpa armigera nucleopolyhedrovirus
  • Myconate® Isoflavone - formononetin
  • Myconate® Isoflavone - formononetin
  • TX Lagenidium giganteum (Laginex®) + TX, Lecanicillium longisporum (Vertiblast®) + TX, Lecanicillium muscarium (Vertiki I®) + TX, Lymantria Dispar nucleopolyhedrosis virus (Disparvirus®) + TX, Marinococcus halophilus + TX, Meira geulakonigii + TX, Metarhizium anisopliae (Met52®) + TX, Metarhizium anisopliae (Destruxin WP®) + TX, Metschnikowia fruticola (Shemer®) + TX, Metschnikowia pulcherrima + TX, Microdochium dimerum (Antibot®) + TX, Micromonospora coerulea + TX, Microsphaeropsis ochracea + TX, Muscodor albus 620 (Muscudor®)
  • TX Phytophthora palmivora (Devine®) + TX, Pichia anomala + TX, Pichia guilermondii + TX, Pichia membranaefaciens + TX, Pichia onychis + TX, Pichia stipites + TX, Pseudomonas aeruginosa + TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®) + TX, Pseudomonas cepacia + TX,
  • Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, Pseudomonas fluorescens strain A506 (BlightBan A506®) + TX, Pseudomonas putida + TX, Pseudomonas reactans + TX, Pseudomonas spp.
  • TX Scytalidium uredinicola + TX, Spodoptera exigua nuclear polyhedrosis virus (Spod-X® + TX, Spexit®) + TX, Serratia marcescens + TX, Serratia plymuthica + TX, Serratia spp. + TX, Sordaria fimicola + TX, Spodoptera littoralis nucleopolyhedrovirus (Littovir®) + TX,
  • Trichoderma asperellum T34 Biocontrol®
  • Trichoderma gamsii TX
  • Trichoderma atroviride Plantmate®
  • Trichoderma harzianum rifai Mycostar®
  • Trichoderma harzianum T-22 Trianum- P® + TX, PlantShield HC® + TX, RootShield® + TX, Trianum-G®) + TX, Trichoderma harzianum T-39 (Trichodex®) + TX, Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma spp.
  • LC 52 (Sentinel®) + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma taxi + TX, Trichoderma virens + TX, Trichoderma virens (formerly Gliocladium virens GL-21 ) (SoilGuard®) + TX, Trichoderma viride + TX, Trichoderma viride strain ICC 080 (Remedier®) + TX, Trichosporon pullulans + TX, Trichosporon spp. + TX,
  • pheromones including: blackheaded fireworm pheromone (3M Sprayable Blackheaded Fireworm Pheromone®) + TX, Codling Moth Pheromone (Paramount dispenser-(CM)/ Isomate C-Plus®) + TX, Grape Berry Moth Pheromone (3M MEC-GBM Sprayable Pheromone®) + TX, Leafroller pheromone (3M MEC - LR Sprayable Pheromone®) + TX, Muscamone (Snip7 Fly Bait® + TX, Starbar Premium Fly Bait®) + TX, Oriental Fruit Moth Pheromone (3M oriental fruit moth sprayable pheromone®) + TX, Peachtree Borer Pheromone (Isomate-P®) + TX, Tomato Pinworm Pheromone (3M Sprayable pheromone®) + TX, Entostat powder (extract from palm tree) (Exosex CM®) + TX, (E + TX,Z +
  • TX Coccidoxenoides perminutus (Planopar®) + TX, Coccophagus cowperi + TX, Coccophagus lycimnia + TX, Cotesia flavipes + TX, Cotesia plutellae + TX, Cryptolaemus montrouzieri (Cryptobug® + TX, Cryptoline®) + TX, Cybocephalus nipponicus + TX, Dacnusa sibirica + TX, Dacnusa sibirica
  • Diglyphus isaea (Diminex®) + TX, Delphastus catalinae (Delphastus®) + TX, Delphastus pusillus + TX, Diachasmimorpha krausii + TX, Diachasmimorpha longicaudata + TX, Diaparsis jucunda + TX, Diaphorencyrtus aligarhensis + TX, Diglyphus isaea + TX, Diglyphus isaea (Miglyphus® + TX, Digline®) + TX, Dacnusa sibirica (DacDigline® + TX, Minex®) + TX, Diversinervus spp.
  • TX Psyttalia concolor (complex) + TX, Quadrastichus spp. + TX, Rhyzobius lophanthae + TX, Rodolia cardinalis + TX, Rumina decollate + TX, Semielacher petiolatus + TX, Sitobion avenae (Ervibank®) + TX, Steinernema carpocapsae (Nematac C® + TX, Millenium® + TX, BioNem C® + TX, NemAttack®
  • TX Steinernematid spp. (Guardian Nematodes®) + TX, Stethorus punctillum (Stethorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Torymus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator, and
  • the active ingredient mixture of the compounds of formula (I) selected from Tables 1 to 96 (including 1a to 96a to 1 m to 96m) and Table A with active ingredients described above comprises a compound selected from Tables 1 to 96 (including 1a to 96a to 1 m to 96m) and Table A and an active ingredient as described above preferably in a mixing ratio of from 100: 1 to 1 :6000, especially from 50:1 to 1 :50, more especially in a ratio of from 20: 1 to 1 :20, even more especially from 10:1 to 1 :10, very especially from 5: 1 and 1 :5, special preference being given to a ratio of from 2:1 to 1 :2, and a ratio of from 4: 1 to 2: 1 being likewise preferred, above all in a ratio of 1 :1 , or 5: 1 , or 5:2, or 5:3, or 5:4, or 4:1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2: 1 , or 1 :5, or 2:5,
  • the mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
  • the mixtures comprising a compound of formula (I) selected from Tables 1 to 96 (including 1a to 96a to 1 m to 96m) and Table A and one or more active ingredients as described above can be applied, for example, in a single“ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a“tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days.
  • the order of applying the compounds of formula (I) selected from Tables 1 to 96 (including 1a to 96a to 1 m to 96m) and Table A and the active ingredients as described above is not essential for working the present invention.
  • compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
  • auxiliaries such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides
  • compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • compositions that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention.
  • Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient.
  • the rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha.
  • a preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question.
  • the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field.
  • the compounds of the invention and compositions thereof are also be suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type.
  • the propagation material can be treated with the compound prior to planting, for example seed can be treated prior to sowing.
  • the compound can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling.
  • These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention.
  • Typical treatment rates would depend on the plant and pest/fungi to be controlled and are generally between 1 to 200 grams per 100 kg of seeds, preferably between 5 to 150 grams per 100 kg of seeds, such as between 10 to 100 grams per 100 kg of seeds.
  • seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corns, bulbs, fruit, tubers, grains, rhizomes, cuttings, cut shoots and the like and means in a preferred embodiment true seeds.
  • the present invention also comprises seeds coated or treated with or containing a compound of formula (I).
  • coated or treated with and/or containing generally signifies that the active ingredient is for the most part on the surface of the seed at the time of application, although a greater or lesser part of the ingredient may penetrate into the seed material, depending on the method of application.
  • the seed product When the said seed product is (re)planted, it may absorb the active ingredient.
  • the present invention makes available a plant propagation material adhered thereto with a compound of formula (I). Further, it is hereby made available, a composition comprising a plant propagation material treated with a compound of formula (I).
  • Seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting.
  • the seed treatment application of the compound formula (I) can be carried out by any known methods, such as spraying or by dusting the seeds before sowing or during the sowing/planting of the seeds.
  • the invention further relates to a pesticidal composition, which comprises at least one compound of formula (I) according to this invention or at least one compound of formula (lb) or, where appropriate, a tautomer thereof, in each case in free form or in agrochemically utilizable salt form, as active ingredient.
  • the invention further relates to a method for controlling pests, which comprises applying a composition according to the invention to the pests or their environment preferably with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
  • the invention further relates to a method for the protection of plant propagation material from the attack by pests, which comprises treating the propagation material or the site, where the propagation material is planted, with a composition comprising a compound according to this invention or with a compound according to this invention.
  • the invention further relates to a plant propagation material treated with the pesticidal composition comprising a compound according to this invention or with a compound according to this invention.
  • the compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm or 0.8 ppm, 0.4 ppm, 0.2 ppm, 0.1 ppm or even at lower concentrations. Temperatures are given in degrees Celsius; mixing ratios of solvents are given in parts by volume.
  • Mp melting point in °C. Free radicals represent methyl groups. 1 H NMR measurements were recorded on a Brucker 400MHz spectrometer, chemical shifts are given in ppm relevant to a TMS standard. Spectra measured in deuterated solvents as indicated.
  • Example 1 Preparation of 4-[3-(3.5-dichlorophenvD-3-(trifluoronnethvDpyrrolidin-1-vn-2-nnethyl-N-(1- methylsulfonylazetidin-3-vDbenzannide (compound A3).
  • This compound was prepared using a library synthesis approach as described below:
  • Diabrotica balteata (Corn root worm)
  • Maize sprouts placed onto an agar layer in 24-well microtiter plates were treated with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions by spraying. After drying, the plates were infested with L2 larvae (6 to 10 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 4 days after infestation.
  • the following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: A1 , A2, A3, A4, A5, A6, A7, A8, A9, A10, A1 1 , A12, A13, A14, A15, A16, A17, A18
  • Soybean leaves on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions. After drying the leaves were infested with N2 nymphs. The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.
  • the following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: A1 , A2, A3, A4, A5, A6, A7, A8, A10, A1 1 , A12, A13, A14, A15, A17.
  • Myzus persicae (Green peach aphid): Feeding/Contact activity
  • Sunflower leaf discs were placed onto agar in a 24-well microtiter plate and sprayed with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions. After drying, the leaf discs were infested with an aphid population of mixed ages. The samples were assessed for mortality 6 days after infestation.
  • the following compounds resulted in at least 80% mortality at an application rate of 200 ppm: A1 , A2, A4, A5, A7, A8, A14.
  • 24-well microtiter plates with artificial diet were treated with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions by pipetting. After drying, the plates were infested with L2 larvae (10 to 15 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.
  • the following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: A1 , A2, A3, A4, A5, A6, A7, A8, A10, A1 1 , A13, A14, A15, A17
  • Spodoptera littoralis (Egyptian cotton leaf worm) Cotton leaf discs were placed onto agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions. After drying the leaf discs were infested with five L1 larvae. The samples were assessed for mortality, anti-feeding effect, and growth inhibition in comparison to untreated samples 3 days after infestation. Control of Spodoptera littoralis by a test sample is given when at least one of the categories mortality, anti-feedant effect, and growth inhibition is higher than the untreated sample.
  • Tetranychus urticae (Two-spotted spider mite): Feeding/contact activity
  • Bean leaf discs on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions. After drying the leaf discs were infested with a mite population of mixed ages. The samples were assessed for mortality on mixed population (mobile stages) 8 days after infestation.
  • Thrips tabaci Onion thrips
  • Sunflower leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10 ⁇ 00 ppm DMSO stock solutions. After drying the leaf discs were infested with a thrips population of mixed ages. The samples were assessed for mortality 6 days after infestation. The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: A1 , A2, A4, A5, A6, A7, A8, A11 , A13, A14, A15, A18

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés de formule (I), dans laquelle les substituants sont tels que définis dans la revendication 1, et leurs sels, stéréoisomères, énantiomères, tautomères et N-oxydes agrochimiquement acceptables, ainsi que leurs utilisations en tant qu'insecticides.
PCT/EP2019/065896 2018-06-19 2019-06-17 Composés insecticides Ceased WO2019243263A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18178654.2 2018-06-19
EP18178654 2018-06-19

Publications (1)

Publication Number Publication Date
WO2019243263A1 true WO2019243263A1 (fr) 2019-12-26

Family

ID=62712928

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/065896 Ceased WO2019243263A1 (fr) 2018-06-19 2019-06-17 Composés insecticides

Country Status (1)

Country Link
WO (1) WO2019243263A1 (fr)

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524206A (en) 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US5631072A (en) 1995-03-10 1997-05-20 Avondale Incorporated Method and means for increasing efficacy and wash durability of insecticide treated fabric
WO2000015615A1 (fr) 1998-09-15 2000-03-23 Syngenta Participations Ag Pyridinecetones utilises comme herbicides
WO2003034823A1 (fr) 2001-10-25 2003-05-01 Siamdutch Mosquito Netting Company Limited Traitement d'une matiere textile au moyen d'un insecticide
US20050148792A1 (en) 2004-01-02 2005-07-07 Damodaragounder Gopal Process for the preparation of gabapentin
WO2005064072A2 (fr) 2003-12-22 2005-07-14 Basf Aktiengesellschaft Composition destinee a l'impregnation de fibres, de tissus et de nappes de filet possedant une activite protectrice contre les parasites
WO2005077934A1 (fr) 2004-02-18 2005-08-25 Ishihara Sangyo Kaisha, Ltd. Anthranilamides, procédé pour la production de ceux-ci et agents antiparasitaires contenant ceux-ci
WO2005113886A1 (fr) 2004-05-12 2005-12-01 Basf Aktiengesellschaft Procede de traitement de substrats flexibles
WO2006087343A1 (fr) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Anilides d'acide carboxylique pyrazole, procedes de production associes et agents les contenant pour la lutte antifongique
EP1724392A2 (fr) 2005-05-04 2006-11-22 Fritz Blanke Gmbh & Co. Kg Procédé d'apprêtage anti-microbien de surfaces textiles
WO2006128870A2 (fr) 2005-06-03 2006-12-07 Basf Aktiengesellschaft Composition pour impregnation de fibres, tissus et filets a action protectrice contre les ravageurs
WO2007026965A1 (fr) 2005-09-02 2007-03-08 Nissan Chemical Industries, Ltd. Composé de benzamide à substitution isoxazoline et agent de lutte contre les organismes nuisibles
WO2007048556A1 (fr) 2005-10-25 2007-05-03 Syngenta Participations Ag Dérivés d'amides hétérocycliques utiles en tant que microbiocides
WO2007074789A1 (fr) 2005-12-26 2007-07-05 Nissan Chemical Industries, Ltd. Compose de 1,3-bis(phenyle substitue)-3-hydroxypropan-1-one ou 2-propen-1-one et son sel
WO2007090739A1 (fr) 2006-02-03 2007-08-16 Basf Se Procede de traitement de substrats
WO2008151984A1 (fr) 2007-06-12 2008-12-18 Basf Se Formulation aqueuse et processus d'imprégnation de matières non vivantes exerçant une action protectrice contre les parasites
WO2009080250A2 (fr) 2007-12-24 2009-07-02 Syngenta Participations Ag Composés insecticides
WO2010060231A1 (fr) 2008-11-25 2010-06-03 Qin Zhaohai Aminonitroguanidines condensées, leur synthèse et leur emploi en tant qu'insecticides botaniques
WO2010149506A1 (fr) 2009-06-22 2010-12-29 Syngenta Participations Ag Composés insecticides
WO2011067272A1 (fr) 2009-12-01 2011-06-09 Syngenta Participations Ag Composés insecticides à base de dérivés isoxazoline
WO2012035011A1 (fr) 2010-09-15 2012-03-22 Bayer Cropscience Ag Arylpyrrolidines pesticides
WO2012092115A1 (fr) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Pesticides à base pyrido[1,2-a]pyrimidines mésoioniques
WO2013092943A1 (fr) * 2011-12-23 2013-06-27 Basf Se Composés isothiazolines pour combattre les organismes nuisibles invertébrés
WO2018114790A1 (fr) * 2016-12-19 2018-06-28 Syngenta Participations Ag Dérivés d'isoxazoline sulfonamides d'azétidine à action pesticide

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524206A (en) 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US5631072A (en) 1995-03-10 1997-05-20 Avondale Incorporated Method and means for increasing efficacy and wash durability of insecticide treated fabric
WO2000015615A1 (fr) 1998-09-15 2000-03-23 Syngenta Participations Ag Pyridinecetones utilises comme herbicides
WO2003034823A1 (fr) 2001-10-25 2003-05-01 Siamdutch Mosquito Netting Company Limited Traitement d'une matiere textile au moyen d'un insecticide
WO2005064072A2 (fr) 2003-12-22 2005-07-14 Basf Aktiengesellschaft Composition destinee a l'impregnation de fibres, de tissus et de nappes de filet possedant une activite protectrice contre les parasites
US20050148792A1 (en) 2004-01-02 2005-07-07 Damodaragounder Gopal Process for the preparation of gabapentin
WO2005077934A1 (fr) 2004-02-18 2005-08-25 Ishihara Sangyo Kaisha, Ltd. Anthranilamides, procédé pour la production de ceux-ci et agents antiparasitaires contenant ceux-ci
WO2005113886A1 (fr) 2004-05-12 2005-12-01 Basf Aktiengesellschaft Procede de traitement de substrats flexibles
WO2006087343A1 (fr) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Anilides d'acide carboxylique pyrazole, procedes de production associes et agents les contenant pour la lutte antifongique
EP1724392A2 (fr) 2005-05-04 2006-11-22 Fritz Blanke Gmbh & Co. Kg Procédé d'apprêtage anti-microbien de surfaces textiles
WO2006128870A2 (fr) 2005-06-03 2006-12-07 Basf Aktiengesellschaft Composition pour impregnation de fibres, tissus et filets a action protectrice contre les ravageurs
WO2007026965A1 (fr) 2005-09-02 2007-03-08 Nissan Chemical Industries, Ltd. Composé de benzamide à substitution isoxazoline et agent de lutte contre les organismes nuisibles
WO2007048556A1 (fr) 2005-10-25 2007-05-03 Syngenta Participations Ag Dérivés d'amides hétérocycliques utiles en tant que microbiocides
WO2007074789A1 (fr) 2005-12-26 2007-07-05 Nissan Chemical Industries, Ltd. Compose de 1,3-bis(phenyle substitue)-3-hydroxypropan-1-one ou 2-propen-1-one et son sel
WO2007090739A1 (fr) 2006-02-03 2007-08-16 Basf Se Procede de traitement de substrats
WO2008151984A1 (fr) 2007-06-12 2008-12-18 Basf Se Formulation aqueuse et processus d'imprégnation de matières non vivantes exerçant une action protectrice contre les parasites
WO2009080250A2 (fr) 2007-12-24 2009-07-02 Syngenta Participations Ag Composés insecticides
WO2010060231A1 (fr) 2008-11-25 2010-06-03 Qin Zhaohai Aminonitroguanidines condensées, leur synthèse et leur emploi en tant qu'insecticides botaniques
WO2010149506A1 (fr) 2009-06-22 2010-12-29 Syngenta Participations Ag Composés insecticides
WO2011067272A1 (fr) 2009-12-01 2011-06-09 Syngenta Participations Ag Composés insecticides à base de dérivés isoxazoline
WO2012035011A1 (fr) 2010-09-15 2012-03-22 Bayer Cropscience Ag Arylpyrrolidines pesticides
WO2012092115A1 (fr) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Pesticides à base pyrido[1,2-a]pyrimidines mésoioniques
WO2013092943A1 (fr) * 2011-12-23 2013-06-27 Basf Se Composés isothiazolines pour combattre les organismes nuisibles invertébrés
WO2018114790A1 (fr) * 2016-12-19 2018-06-28 Syngenta Participations Ag Dérivés d'isoxazoline sulfonamides d'azétidine à action pesticide

Non-Patent Citations (25)

* Cited by examiner, † Cited by third party
Title
"Journal of the Chemical Society, Perkin Transactions 1", ORGANIC AND BIO-ORGANIC CHEMISTRY, vol. 1, 1972, pages 153 - 7
"Manual on Development and Use of FAO and WHO Specifications for Pesticides", 2010, UNITED NATIONS
"McCutcheon's Detergents and Emulsifiers Annual", 1981, MC PUBLISHING CORP.
A. WOOD: "The Pesticide Manual - A World Compendium", 1995, THE BRITISH CROP PROTECTION COUNCIL
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 20, no. 1, 2010, pages 362 - 365
CHEM. EUR. J., vol. 9, 2003, pages 4442 - 4451
J. AM. CHEM. SOC., vol. 130, 2008, pages 6072 - 6073
J. AM. CHEM. SOC., vol. 132, no. 10, 2010, pages 3258 - 3259
J. MED. CHEM., vol. 32, no. 12, 1989, pages 2561 - 73
J. ORG. CHEM., vol. 73, 2008, pages 3475 - 3480
JOURNAL OF MEDICINAL CHEMISTRY, vol. 33, no. 2, 1990, pages 849 - 54
JOURNAL OF ORGANIC CHEMISTRY, vol. 46, no. 4, 1981, pages 771
JOURNAL OF ORGANIC CHEMISTRY, vol. 55, no. 13, 1990, pages 4156 - 62
JOURNAL OF ORGANIC CHEMISTRY, vol. 61, 1996, pages 1986
JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 67, no. 7, 1978, pages 953 - 6
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 133, 2011, pages 6403 - 6410
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 71, 1949, pages 3554 - 5
M. BARTOK ET AL., J. ORGANOMET. CHEM., vol. 297, 1985, pages C37 - C40
M. MORI ET AL., J. ORG. CHEM., vol. 65, 2000, pages 3966 - 3970
ORGANIC LETTERS, vol. 8, no. 21, 2006, pages 4811 - 4813
T. W. GREENP. G. M. WUTS: "Protective Groups in Organic Synthesis", vol. 564-566, 1999, WILEY-INTERSCIENCE, pages: 740 - 743
TETRAHEDRON LETTERS, vol. 34, no. 20, 1993, pages 3279 - 82
TETRAHEDRON, vol. 52, no. 1, 1996, pages 59 - 70
TETRAHEDRON: ASYMMETRY, vol. 10, no. 20, 1999, pages 3877 - 3881
TETRAHEDRON: ASYMMETRY, vol. 14, no. 1, 2003, pages 113 - 117

Similar Documents

Publication Publication Date Title
EP3240786B1 (fr) Dérivés polycycliques à activité pesticide comportant des substituants contenant du soufre
EP3353172B1 (fr) Benzamides et analogues substitués par une isoxazoline en tant qu'insecticides
EP3177620A1 (fr) Dérivés hétérocycliques à activité pesticide comportant des substituants contenant du soufre
EP3555081B1 (fr) Dérivés d'isoxazoline amide de sulfones d'azétidine actifs sur le plan pesticide
EP3601241B1 (fr) Dérivés de cyclopropyl-méthyle amide à action pesticide
US11001577B2 (en) Pesticidally active azetidine sulfones amide isoxazoline derivatives
WO2020064564A1 (fr) Composés insecticides
US11104671B2 (en) Insecticidal compounds
EP3810605A1 (fr) Dérivés d'isoxazoline d'amide d'azétidine à action pesticide
EP3810604A1 (fr) Dérivés d'isoxazoline à action pesticide contenant un groupe amide et un groupe azétidine sulfone
WO2020025658A1 (fr) Composés hétéroaromatiques bicycliques à action pesticide
WO2020030754A1 (fr) Composés hétéroaromatiques bicycliques mésoioniques à action pesticide
US11213032B2 (en) Insecticidal compounds
WO2019243263A1 (fr) Composés insecticides
WO2020120694A1 (fr) Composés hétéroaromatiques bicycliques à action pesticide
EP3810603A1 (fr) Dérivés d'isoxazoline à action pesticide contenant un groupe amide et un groupe azétidine sulfone
WO2020035565A1 (fr) Composés hétéroaromatiques bicycliques mésoioniques à action pesticide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19733429

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19733429

Country of ref document: EP

Kind code of ref document: A1